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ABSTRACT 
 
To improve the methodology of HIV-1 cluster analysis, we addressed how analysis of HIV-1 
clustering is associated with parameters that can affect the outcome of viral clustering. The 
extent of HIV clustering, tree certainty, subtype diversity ratio (SDR), subtype diversity 
variance (SDV) and Shimodaira-Hasegawa (SH)-like support values were compared between 
2881 HIV-1 full genome sequences and sub-genomic regions of which 2567 were retrieved 
from the LANL HIV Database and 314 were sequenced from blood samples from a cohort in 
KwaZulu-Natal. Sliding window analysis was based on 99 windows of 1000 bp, 45 windows of 
2000 bp and 27 windows of 3000 bp. Clusters were enumerated for each window sequence 
length, and the optimal sequence length for cluster identification was probed. Potential 
associations between the extent of HIV clustering and sequence length were also evaluated. The 
phylogeny based on the full-genome sequences showed the best tree accuracy; it ranked highest 
with regards to both tree certainty and SH-like support. Product 4, a region associated with env, 
had the best tree accuracy among the sub-genomic regions. Among the HIV-1 structural genes, 
env had the best tree certainty, SH-like support, SDR score and the best SDV score overall. The 
hierarchy of cluster phylotype enumeration mirrored the tree accuracy analysis, with the full 
genome phylogeny showing the highest extent of clustering, and the product 4 region being 
second best. Among the structural genes, the highest number of phylotypes was enumerated 
from the pol phylogeny, followed by env. The extent of HIV-1 clustering was slightly higher for 
sliding windows of 3 000 bp than 2000 bp and 1000 bp, thus 3000 bp was found to be the 
optimal length for phylogenetic cluster analysis. We found a moderate association between the 
length of sequences used and proportion of HIV sequences in clusters; the influence of viral 
sequence length may have been diminished by the substantial number of taxa. Full-genome 
sequences could provide the most informative HIV cluster analysis. Selected sub-genomic 
regions with the best combination of high extent of HIV clustering and high tree accuracy, such 
as env, could also be considered as a second choice. 
 
Key words: HIV-1, viral cluster analysis, tree accuracy, sequence length, sub-genomic region 
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CHAPTER ONE: INTRODUCTION 
 
 
The human immunodeficiency viruses (HIV-1 and HIV-2) are the etiologic agents for AIDS in 
humans1-3. AIDS is a condition in which progressive failure of the immune system allows life-
threatening opportunistic infections and cancers to thrive; it is arguably one of the most 
devastating infectious diseases to emerge in modern times4. Despite advancements in HIV 
prevention over the past 30 years, an estimated 2.1 million persons were newly infected in 2015, 
bringing the number of people living with HIV worldwide to 36.7 million5. While cases have 
been reported in all regions of the world, 95% of new infections occur in individuals living in 
low- and middle-income countries. The HIV burden continues to be greatest in sub-Saharan 
Africa; this region accounts for approximately 70% (25.8 million) of worldwide infections6.   
 
The virus itself belongs to the group of retroviruses known as lentiviruses or “slow viruses”, 
which are characterized by a long interval between infection and disease development7. These 
are spherical in shape, roughly 80 – 100 nm in diameter and possess two usually identical 
copies of a single stranded RNA genome approximately 10kb in length8. Following reverse 
transcription the genome must integrate into the host cell’s DNA in order to replicate. The 
lifecycle within an individual host is characterized by exceptionally high replication9, 10, 
mutation11 and recombination12, 13 rates which combined with the positive selection, promoted 
by the hosts immune response10, 14, result in the huge amount of diversity observed at both an 
intra – as well as at an inter – host level15, 16.  
 
The pandemic of HIV infection continues to pose an enormously difficult public health 
challenge for a multitude of reasons. HIV-1 continually evolves and migrates through individual 
hosts, overcoming barriers to transmission, avoiding different immune responses, and resisting 
various antiretroviral regimens. Immunological host restriction factors in the form of proteins 
such as TRIM5/22, APOBEC, and Tetherin have been to some extent ineffective in blocking 
early HIV-1 infection17-20. Highly Active Antiretroviral Therapy (HAART) has been very 
effective at reducing viral loads within patients and thereby significantly prolonging life 
expectancy for HIV infected individuals, particularly in those countries where HAART is 
accessible. However, even when HAART is available, effective control remains elusive due to 
the number of evolved mechanisms that HIV uses to evade the host immune system21, 22 the 
evolution of drug resistance23, 24, and the isolation of viral reservoirs from drug treatments25, 26. 
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Over the past thirty years, HIV-1/AIDS has evolved into an increasingly heterogeneous disease 
composed of multiple epidemics each influenced by a complex array of biological, behavioral, 
and cultural factors27. The extremely high level of genetic diversity among the 9 recognized 
global pure subtypes and at least 88 circulating recombinant forms is one of the most daunting 
aspects of the HIV epidemic28.  It has been postulated that viral sequence variability may dictate 
biologic differences that partially explain the different epidemic patterns seen in different 
regions of the world. Several reports have documented that HIV-1 subtypes may differ with 
respect to viral load29, chemokine co-receptor usage30, transcriptional activation levels31 and 
antiretroviral drug susceptibility32.   
 
While our knowledge of HIV biology is still limited, we have gained significant insights 
through the application of phylogenetics to HIV diversity. Phylogeny provides a unique 
framework to capture underlying structures of transmission networks that could not be 
otherwise identified33, 34. Phylogenetics can identify the genetic interrelatedness of viruses in 
HIV-infected persons34. The “clustering” of sequences can infer transmission networks whereby 
dynamic HIV spread can be assessed on chronological and stage of infection time scales. 
Phylogenetic cluster analysis can be combined with epidemiological, demographic, and 
behavioural data to describe the underlying factors contributing to the growth of individual 
epidemics35. Without the immediate prospect of a broadly effective vaccine for HIV-1, the study 
of HIV transmission networks provides insight into the spread of HIV, and thus into 
opportunities for intervention33, 36-39. 
Justification 
 
A major goal of public health in relation to HIV/AIDS is to prevent new transmissions in 
communities. A better understanding of the structure and dynamics of HIV transmission 
through comprehensive HIV cluster analysis could facilitate the achievement of this goal33, 40-48. 
However, there is confusion surrounding HIV clustering due to differences in sampling, 
methodological approaches, and interpretation of HIV clustering results across studies.  
Presently, there has been interest in seeking to establish how the selection of region across the 
HIV-1 genome and its length affects the extent of HIV clustering. The choice of gene fragment 
for the reconstruction of phylogenies is crucial as it has been documented that phylogenetic 
trees constructed from different genes frequently contradict each other, giving rise to 
incongruence49, 50. Several studies examining hundreds of genes in fungi51, 52, plants53 and 
mammals54 found that the vast majority of gene trees are not topologically congruent either with 
each other or with the species phylogeny. 
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With regards to HIV-1 phylogenetic analysis, the HIV-1 pol gene has been predominantly used 
for phylogenetic reconstruction of transmission events35 and for HIV cluster analysis over the 
past decade33, 41-43, 45-48. Although initially the env gene was considered to present the strongest 
phylogenetic signal, it was argued that some env fragments were too short and/or variable for a 
robust analysis55. After pol was demonstrated to accurately reconstruct HIV transmission35 , its 
analysis for phylogenetic studies became the standard due to the fact that HIV-1 pol sequences 
are generated as a part of routine clinical care and thus very large datasets are available for 
analysis. In the last few years, the increasing availability of HIV whole genome sequences has 
made possible the analysis of other genetic regions, which has raised discussion about whether 
full-length genome trees should be used or which viral genes provide the best trees. 
 
Leitner et al. explored this very issue in a study that evaluated the contribution of different 
regions across the HIV-1 genome to the reconstruction of viral phylogeny. Their findings 
highlighted the importance of the choice of the HIV-1 gene fragment for reconstruction of true 
phylogeny, and showed that combining data on gag p17 and env V3 performed better than data 
on either p17 or V3 evaluated separately56. Results of a study conducted by Harris et al. in 
Ethiopia also support the notion of the importance of target gene selection in HIV-1 cluster 
analysis. Phylogenies reconstructed from sub-genomic regions showed a weaker clustering 
relative to the near full-length genome phylogenies57; however, the study was limited by the 
small set of viral sequences analyzed. In a study also exploring the parameters that may affect 
the outcomes of viral clustering, Novitsky et al. hypothesized that the size, complexity, and 
number of variable or informative sites in the multiple sequence alignment are important factors 
that impact the extent of HIV clustering58. Their analyses elucidated that the extent of detectable 
HIV clustering is directly associated with the length of viral sequences used, as well as the 
number of variable and informative sites.  
 
A common conclusion amongst previous studies is that the combination of more than one gene 
provides the best estimation of the true tree. However, all were limited to small sample sizes, 
and, in some cases, short nucleotide sequences. Additionally, demographic and socioeconomic 
data, as well as stage of HIV infection at the time of sampling, were unavailable for most 
sequences. There is thus a need to further investigate the parameters that influence the outcomes 
of viral clustering, examined in a multifaceted manner, using bigger and more comprehensive 
data.  The nature of this influence could help inform the choice of design in studies employing 
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HIV cluster analysis. It could also help in making choices regarding how subjects are sampled, 
requirements for laboratory facilities, duration of studies, and budget.  
 
To improve the methodology of HIV cluster analysis, we addressed how analysis of HIV 
clustering is associated with parameters that can affect the outcome of viral clustering patterns 
of HIV-1. This is imperative as the extent of viral clustering is one of the key factors in making 
inferences about epidemiologic processes inferred from viral phylogenies. 
 
1. Literature Review 
 
In the following section the history and current epidemiology of the HIV pandemic, HIV-1 
genomic structure, the genetic diversity of HIV-1, phylogenetic methods commonly used in the 
analysis of HIV, factors that may influence the outcomes of HIV cluster analysis, as well as 
phylogeny accuracy assessment methods, will be briefly reviewed. 
 
1.1. History and present epidemiology of the HIV pandemic 
 
In 1981, several homosexual men presented with a variety of unusual symptoms at different 
hospitals and clinics throughout the USA. These men suffered from opportunistic infections 
such as; Pneumocystis jiroveci pneumonia, oral thrush, high viral loads for cytomegalovirus 
(CMV), and a malignant cancer called Kaposi`s Sarcoma (KS). Close investigation also 
revealed that the majority of the men had very low T-cell counts, which indicated an immune 
dysfunction. These opportunistic infections, all coinciding in otherwise healthy young men, 
prompted doctors to submit a paper to be included in the Center for Disease Control and 
Prevention´s (CDC’s) Morbidity and Mortality Weekly Report (MMWR) weekly newsletter59. 
These symptoms all coincided in people from the same demographic and social background, 
and their association with a compromised immune system, in particular lower levels of T cells60, 
led doctors to believe that they were dealing with a new unknown disease. In these early days 
doctors called this new disease GRID, or Gay-Related Immune Deficiency, but by the end of 
the year similar cases of the disease where starting to appear in the heterosexual population61. 
 
The first group in the general heterosexual population to present with these unusual symptoms 
were intravenous drug users (IVDU´s). The second group was young Haitian immigrants in the 
USA59. Shortly after that, reports of the disease were documented amongst haemophiliacs who 
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had been treated with blood and other blood products62. By the end of 1982 reports of the 
disease in new born babies, who were born to IVDU mothers, were documented63. The 
occurrence of the disease in non-homosexual individuals meant that the acronym GRID was no 
longer appropriate. A new term for this illness, Acquired Immune Deficiency Syndrome or 
AIDS, was suggested in July of 1982 at a meeting in Washington D.C.64. AIDS turned out to be 
an appropriate name because when people acquired the condition, it led to a deficiency within 
the host immune system, and because it was a syndrome, with a wide range of possible 
manifestations, rather than a single disease. 
 
Over the following years, other countries, particularly in Europe and Africa, started to report 
their first cases of AIDS65-67. In May of 1983, Professor Luc Montagnier and his team at the 
Pasteur Institute in Paris reported that they had isolated a new retrovirus from the lymph node of 
a patient suffering from AIDS. The French team named the new isolated virus LAV for 
Lymphadenopathy-Associated Virus68. The findings of the French team were confirmed by 
research teams in the USA69-72. Ratner and co-workers independently confirmed that these new 
viruses, which were isolated by the French and American researchers, were similar to one 
another and also published the first fully sequenced genome of the virus73. 
 
In 2015, 34 years since the first reported cases of AIDS appeared in the USA, HIV-1 global 
infections had reached an estimated 36.7 million5, showing an increase from 35.3 million in 
201274. The largest burden of HIV-1 is found in Sub-Saharan Africa with more than 65% of 
adult worldwide infections75. South Africa has the biggest and most high profile HIV epidemic 
in the world, with an estimated 7 million people living with HIV in 201576. With the expansion 
of the ART treatment programme the number of newly infected people globally had decreased 
from 2.3 million74 to 2.1 million5 between 2012 and 2015. In addition, global deaths decreased 
to nearly 1.1 million by 20155, compared to almost 2.3 million deaths in 200577, an approximate 
50% decrease since the scale-up of ART in the past 10 years. Despite this decrease, HIV is 
presently one of the world’s most prominent infectious killers78. 
1.2. Virion structure and genomic organization of HIV-1 	  
HIV comprises of an outer lipid envelop with glycoproteins, gp120 and gp41, that cover the 
lipid membrane and matrix protein (p17) underneath79. The conical shape of the HIV capsid 
(p24) encloses two copies of the single-stranded RNA genome and the 3 viral enzymes; reverse 
transcriptase, integrase and protease (Figure 1). The HIV-1 genome length is about 9.7-kilo 
base pairs (kbp) and consists of several major genes coding for structural proteins that are found 
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in all retroviruses as well as several nonstructural ("accessory") genes unique to HIV. The HIV 
genome contains three major genes, 5'gag-pol-env-3', encoding major structural proteins as well 
as essential enzymes80. These are synthesized as polyproteins which produce proteins for virion 
interior, called Gag (group specific antigen); the viral enzyme Pol (polymerase) or the 
glycoproteins of the virion env (envelope)81.  A diagrammatic representation of the genomic 
layout of HIV-1 is indicated in Figure 2. 
 
Figure 1: HIV-1 virion structure82. 
 
 
Figure 2: A diagrammatical representation of the genome layout of HIV-1. All three reading frames with 
all the most important genes are shown. All start and stop coordinates of genes on the diagram 
corresponds to that of the HXB2 reference strain. Adapted from83. 
The gag gene codes for the capsid of the virus. The gag gene, which is roughly 1500 base pairs 
(bp) long, is transcribed in one single fragment, which is then spliced into the various 
polyproteins84. The gag p24 part of the gene makes up the viral capsid whereas the gag p6 and 
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gag p7 parts code for the nucleocapsid and gag p17 provides a protective matrix85. The pol  
gene is a common feature of retroviruses86. As with the gag gene, pol is transcribed in a single 
protein, which is then spliced into the four functional polypeptides: reverse transcriptase, the 
RNase, the integrase and the protease87. The function of the reverse transcriptase gene is to 
transcribe the viral RNA to double stranded DNA88. The protease gene is responsible for the 
cleaving/splicing of large protein segments of gag, pol, env, and nef into the separate functional 
units89. The integrase fragment of the pol gene is responsible for the integration of the double 
stranded viral DNA into the host cells genome 90. The env gene encodes for a precursor protein, 
gp 160, which is spliced by the host cellular enzymes into the two functional proteins gp 120 
and gp 4191. Env gp120 is exposed on the surface of the viral envelope and binds the virus to the 
CD4 receptors on the surface of any target cells91. The glycoprotein gp41 is noncovalently 
bound to gp120, and facilitates the second step of viral entry into the target cells92. The gp41 is 
originally found inside the viral envelope, but when gp120 binds to the CD4 receptor, gp120 
undergoes a conformational change causing gp41 to become exposed on the viral envelope, 
where it can assist in the fusion of the virus with the host cell91. 
 
In addition to gag, pol and env, HIV encodes for proteins which have certain regulatory and 
auxiliary functions as well81. HIV-1 has two important regulatory elements: Tat and Rev and 
few important accessory proteins such as Nef, Vpr, Vif and Vpu which are not essential for 
replication in certain tissues80. The gag gene provides the basic physical infrastructure of the 
virus, and pol provides the basic mechanism by which retroviruses reproduce, while the others 
help HIV to enter the host cell and enhance its reproduction. Though they may be altered by 
mutation, all of these genes except rev exist in all known variants of HIV.  
1.3. Genetic diversity of HIV-1 
 
HIV variability is a consequence of at least three features peculiar to the virus (Figure 3). First, 
viral replication is rapid, generating a large number of virions per day (estimated at 
approximately 1010 virions per day in an infected individual)93; second, two or more variants of 
HIV can undergo recombination within the same infected individual and third, HIV RT is 
highly error prone, introducing on average one substitution per genome per replication round94, 
95. The rate of sequence variation across the genome of HIV varies, with the highest degree of 
sequence variation in the env gene, intermediate amounts in the gag and a low degree in the pol 
gene96. As with other RNA viruses, HIV forms complex distributions of closely related but non-
identical genomes that are subject to a continuous process of genetic variation, competition, and 
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selection. These viral quasi-species are highly mutable entities that can quickly adapt to new 
environments and ecological challenges. 
 
 
 
 
Figure 3: Features associated with HIV-1 variability. a) The viral reverse transcriptase is highly error 
prone, resulting in each new virion encoding approximately one mutation. b) Viral recombination in 
CD4+ T cells can also generate HIV-1 genetic variation. When two HIV-1 virions with different genetic 
sequences enter the same cell, they can both integrate and produce viral RNA. Homologous 
recombination or packaging of RNA from parent viruses leads to the creation of entirely new HIV-1 
genomes97. 
Genetic classification of HIV is based on a phylogenetic system, which means that viral isolates 
are grouped into a subtype based on their inferred evolutionary relationship98 rather than on 
other characteristics such as serological reactivity, phenotype, co-receptor usage and many other 
possible biological characteristics, which are routinely used for the classification of other 
viruses. This method sets HIV subtype classification apart from other older viral pathogens 
where serological subtyping is the norm. Four groups of HIV-1 occur, including M, N, O and 
P99. Group M is found worldwide and is the major cause of the HIV epidemic99, whereas 
clusters N, O and P remain mainly in Central West-Africa.   
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The diversity present within the group M is extensive when compared to other rapidly evolving 
viral genomes such as influenza16. When represented on a phylogenetic tree, strains within 
group M form well defined clusters. Nine of these clusters are currently termed subtypes. These 
are labeled A to D, F to H, J and K plus many circular recombination forms (CRFs), such as 
CRF01_AE and CRF02_AG100 101. These subtypes, supported by a low subtype diversity ratio102 
(Figure 4) as well as high bootstrap values103, are roughly equidistant to each other when 
represented on a phylogenetic tree.  They also have long characteristic evolutionary branch 
lengths stretching into them. As a result of these combined characterizes HIV-1 group M’s 
phylogeny is often described as being “double starburst” like in nature. Three group M subtypes 
predominate in the world: subtype A in Central Africa, Western Europe and North America has 
subtype B and, sub-Saharan Africa plus India has subtype C99. HIV-1 subtype C contributes 
approximately 50% of the worldwide HIV infections104.  
 
 
 
Figure 4: Phylogenetic topology of the nine (A, B, C, D, F, G, H, J, K) pure subtypes of HIV-1 group M. 
* indicates bootstrap support of 100%16. 
 1.4. HIV-1 phylogenetic analysis pipeline 	  
HIV was discovered when modern molecular biology and phylogenetic methods became widely 
used. Therefore, the advances in molecular biology such as, DNA amplification and sequencing, 
as well as advances in computer technology and evolutionary biology, have revolutionized HIV 
based research. Since a variety of different phylogenetic methods are used throughout the 
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course of this study it is of importance to briefly introduce some of the basic concepts of 
modern phylogenetic practices. 
1.4.1. An overview of phylogenetics 	  
Broadly, modern molecular phylogeny is the science of estimating evolutionary histories using 
DNA and amino acid sequences. Traditionally, the evolutionary relationships between taxa or 
species were inferred from phenotypic differences or similarities, since the days of Charles 
Darwin. In the early days these trees were drawn by hand and the branching order between the 
different taxa was based on observed phenotypic differences or similarities. In the late 1950‟s 
and early 1960‟s two critical technological advances gave a new impetus to modern 
phylogenetics. These were the advancements in molecular biology (nucleic- and amino acid 
sequence composition) and the development of large centralized computers, which were 
powerful enough to handle complex computations. With the genetic information and 
computational power now readily available, scientists set out to develop algorithmic means of 
analysing the genetic data to infer evolutionary relationships. 
The first major breakthrough came with the development of parsimony methods of inferring 
evolutionary relationships in the early 1960’s105. This method is rooted in the assumption that 
the evolutionary tree that requires the least number of changes to explain the current set of data 
would be the best possible tree topology (most parsimonious). Since the development of 
parsimony methods, several algorithmic processes have been developed to infer evolutionary 
trees. These include the edition of the unweighted pair group method with arithmetic means or 
UPGMA106, 107, the Maximum Likelihood method108, the Fitch-Margoliash method109, the 
Neighbor-Joining method110, the Minimum Evolution method111, and lastly the Bayesian 
method112 of tree inference. These various techniques can broadly be divided into two main 
categories (Table 1) based on the kind of data they use to infer tree topologies: distance based 
methods and character based methods113, 114. 
Table 1: Summary of the various methods of tree construction 
Method Optaimality search crtiterion Clustering algorithm 
Distance based Fitch-Margoliash UPGMA 
 Minimum Evolution Neighbour-joining 
Character based Maximum Parsimony  
 Maximum Likelihood  
 Bayesian Inference  
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In HIV-1 phylogenetics, epidemics are characterized based on the genetic interrelatedness of 
HIV-1 viral sequences, capturing the underlying structure of transmission networks within a 
given population33, 35, 48, 115. HIV-1 phylogenetic analysis initially requires the generation of viral 
sequences, which in most cases, are derived from virions isolated from the peripheral blood of 
infected persons. Once HIV has been isolated from the blood or other body fluids and then 
amplified through a single or series of polymerase chain reactions, a viral sequence can be 
obtained from the resulting viral amplicon. The next step involves the aligning of the different 
sequences with one another in order to obtain position homology. Subsequently, some 
assumption about the evolutionary process needs to be made, for this, an appropriate model of 
nucleotide substitution needs to be selected. Finally the sequence alignment and the inferred 
model of substitution can be used to infer an evolutionary relationship116. A schematic 
breakdown of the basic steps involved in any phylogenetic investigation is presented in Figure 
5.  
 
Figure 5: A breakdown of the basic steps involved in any phylogenetic investigation. The diagram 
illustrates the basic steps involved in the generation of a phylogenetic tree. 	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1.4.2. Generation of viral sequences and retrieval of homologous genetic information 
 
HIV sequencing methodologies include direct Sanger sequencing117, single genome 
amplification or cloning (SGA/cloning)118, and next – generation sequencing (NGS)119. The goal 
of any phylogenetic analysis is to establish the evolutionary relationship between newly 
sequenced data and other known sequences. One of the first steps in any phylogenetic analysis 
is to obtain reference sequences to compare to newly sequenced data in order to establish the 
evolutionary relationship of the newly sequenced information. 
The aim is therefore to obtain enough genetic information that shares a close genetic 
relationship with the new sequence(s) of interest. However, it is important to understand the 
difference between homology and similarity where sequence information is concerned. Genetic 
similarity merely reflects the proportion of sites over the length of sequences that are 
identical120. Homology on the other hand implies that two taxa or sequences are descended from 
a common ancestor and thus will imply that in a sequence alignment identical residues at a site 
are identical by descent120. 
The easiest method to obtain homologous sequence information is to use the Basic Local 
Alignment Search Tool or BLAST method121. BLAST uses the input sequence as a query to 
search databases for any protein or nucleic acid sequence that share similarity. After the search 
is complete the program will produce a list of sequences that it found to be similar to the query 
sequence. The BLAST program also produces an E value for every “hit”, which indicates the 
level of confidence in that particular result. If a sequence E value is below 0.1, one can assume 
with high confidence that the sequence will be a homologue to your query sequence121. 
Currently, the majority of genetic information is stored in online sequence databases, either in a 
nucleic acid or amino acid format. There are a large number of sequence databases in existence, 
the most important of which are: GenBank (at NCBI), EMBL (European Molecular Biology 
Laboratory), and the DDBJ (DNA Data Bank of Japan)122. Over the past two decades, HIV data 
have accumulated rapidly in public and specialized databases thereby creating one of the richest 
datasets we have for a single entity in terms of sequence tallies and epidemiological 
information. For instance, the number of available sequences in the Los Alamos database has 
exploded to 339,306 sequences, a 45% increase over the preceding year, with 2576 complete 
genomes123. Increasing amounts of HIV-1 nucleic acid sequence data of have led to an ever-
growing number of methods to organize and analyze data. 
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1.4.3. Sequence alignments 	  
In the phylogenetic analysis pipeline, these HIV-1 nucleic acid sequences are aligned with each 
other in a multiple sequence alignment. A multiple sequence alignment is a method of arranging 
the different sequences of nucleic or amino acids to identify regions of similarity and form the 
basis of all phylogenetic analysis. Aligned sequences of nucleotides or amino acid residues are 
typically represented as rows within a matrix (Figure 6). Gaps are inserted between the residues 
in order to obtain position homology. Operating under the assumption that two sequences in an 
alignment share a common ancestor, one can interpret mismatches within the alignment as point 
mutations and gaps as indels (indels can be defined as insertions or deletions) which were 
introduced in one or both of the taxa in the time since they diverged124. Most sequences 
alignments require the alignment of large numbers of lengthy, and sometime highly variable, 
sequences that cannot be aligned solely by human effort, thus in the modern digital age, 
algorithms are used for the construction of sequence alignments.  
 
 
Figure 6: DNA sequences given in the form of a multiple sequence alignment 
Even with the development of several alignment algorithms, the quality of most of these 
alignments is still very poor and they require manual editing (with special alignment editing 
tools) in order to obtain accurate codon alignments. Pairwise sequence alignment methods are 
commonly employed to find the best matching alignment of two query sequences and can 
therefore only be used between two sequences at a time124. They are however extremely easy to 
calculate and are therefore often used for methods that do not require extreme precision. 
A multiple sequence alignment is an extension of pairwise alignment to accommodate more 
than two sequences at a time114. This method is often used for the identification of conserved 
sequence regions across a group of sequences, which are related back in time (share a common 
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ancestor). Multiple sequence alignments also form the backbone of modern phylogenetic 
analysis since they are used for the construction of phylogenies114. The most commonly used 
method for the construction of multiple sequence alignment is the progressive method (also 
called the tree method of alignment) in which the program first draws a “guide tree” and then 
aligns sequences according to the tree topology. Taxa that appear within the tree to be most 
closely related are first aligned with one another, then successively less related sequences are 
added to the alignment until the entire set of sequences has been resolved114. 
1.4.4. Nucleotide substitution models 	  
Phylogenetic analysis makes certain assumptions about the process and rate of DNA 
substitutions or amino acid replacements in the model of evolution they employ. Point 
mutations can either be due to transversions (when a purine base is replaced by a pyrimidine 
base) or due to transitions (the replacement of a purine or pyrimidine base with another purine 
or pyrimidine respectively). Due to the chemical similarity between purine bases (Adenine or 
Guanine) or pyrimidine bases (Cytosine or Thymine) transitions (Ts) are more common than 
transversions (Tv), which would alter the chemical composition of the DNA molecule114. To 
study the dynamics of these changes in sequences, one needs to use mathematical algorithms 
that take into account different rates of nucleotide substitution (to allow for transitions to occur 
more often than transversions). To date a large number of these models have been developed, all 
of which allow for different assumptions and conditionalities. 
The first model of nucleotide substitution developed was the Jukes and Cantor method (JC69) in 
1969125. This model operates under the assumption that the equilibrium base frequencies of the 
four nucleotides are 25% for each nucleotide (π1 = π2 = π3 = π4 = ¼). It also assumes that any 
nucleotide has the same probability to be replaced by any of the other three nucleotides. This 
means that the only variable is the overall substitution rate or µ. By taking these considerations 
into account one can see that, although the process can be easily mathematically applied, there 
are some shortcomings to this model of nucleotide substitution. Since the development of the 
JC69 model in the 1960´s, several extensions and improvements have been made, that can allow 
for unequal base frequencies or allow for different rates of transitions and transversions.  
Besides the use of a specific model of nucleotide substitution in evolutionary analysis, one also 
needs to account for variable substitution rates across sites. All of the model(s) that were 
discussed in the preceding section work under the assumption that different sites in a sequence 
evolve in the same way and at the same rate. Such an assumption however, may be unrealistic 
as some areas of a coding region may be more conserved due t
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the secondary structure of proteins. One can account for such rate variations by assuming that 
the rate for any site is a random variable that can be calculated from a statistical distribution. 
The most commonly used distribution to accommodate for rate heterogeneity amongst sites 
today is the gamma distribution (+G). A gamma distribution of 1 across sites for instance will 
mean that all site across the length of the alignment evolve at the same constant rate, while a 
gamma distribution closer to 0 (G < 1) will mean that different parts across the sequence length 
evolve at much different rates. 
1.4.5. Phylogenetic tree structure and inference methods 	  
The resultant phylogenetic tree is a mathematical structure that can be used to graphically depict 
the relationship among sequences within the alignment. The tree itself consists of internal 
nodes, external nodes and edges (Figure 7, A and B). From a biological point of view the 
external nodes (green) are the input sequences. These can also be called leaf nodes. The internal 
nodes (blue) represent the ancestral relationships between these sequences. These eventually 
converge to the root of the tree – the estimated most recent common ancestor. Often a closely 
related sequence, that is not part of the sampled dataset, will be added to the alignment so that it 
is easier to determine where the true root lies within the group. This is referred to as an 
outgroup. The choice of outgroup is essential for understanding the evolution of traits along a 
phylogeny. The chosen outgroup is hypothesized to be closely related to the other groups but 
less closely related than any single one of the other groups is to each other. Edge lengths 
connecting the nodes represent the amount of change that occurs between each node. In 
summary, HIV phylogenies are evolutionary trees in which the leaves of the tree are the 
sampled sequences or taxa, branches are the genetic distance between taxa, and the nodes 
denote estimated speciation events126. There are a number of programs for inferring phylogenies 
including, but not limited to, PAUP*127, BAMBE128, BEAST129, PHYLIP130, RAxML131 and 
MrBayes132.  
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(A)        (B) 
Figure 7: Phylogenetic tree structures. (A) A tree inferred from 13 HIV-1 sequences labelled A – M. (B) 
Identical tree but represented using a different trigonometric pattern.  
Phylogenetic trees are generally inferred based on an optimality criterion. Most commonly 
utilized methods are distance based methods and evolutionary methods. Distance based 
methods, such as Neighbor-Joining133 and UPGMA106, explicitly rely on a measure of genetic 
distance between operational taxonomic units (OTUs = [neighbours]) based on their sequence 
differences. Distance measures are derived from pairwise comparisons of the sequences. 
Whereas the distance based methods represent sequence divergence by a single number, the 
evolutionary methods attempt to infer the phylogeny by fitting individual characters 
(nucleotides or amino acids) to the tree. Most popular approaches for evolutionary methods are 
maximum likelihood134, maximum parsimony135. 
The parsimony score is the minimum number of character changes implied by a tree given a 
multiple sequence alignment. Thus the principle of parsimony as applied to phylogenetics, 
states that the topology that requires the fewest evolutionary changes is the one that should be 
assumed as correct. A smaller parsimony score indicates a better tree. Parsimony-based methods 
count the total number of substitutions in the tree by summing the substitutions between 
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sequences of every pair of adjacent nodes. Sequences for internal nodes may be reconstructed 
using algorithms such as the Sankoff algorithm136. The maximum likelihood method is broadly 
similar to the maximum-parsimony method, but maximum likelihood allows additional 
statistical flexibility by permitting varying rates of evolution across both lineages and sites. In 
fact, the method requires that evolution at different sites and along different lineages must be 
statistically independent. Maximum likelihood is thus well suited to the analysis of distantly 
related sequences, but it is believed to be computationally intractable to compute due to its NP-
hardness137.   
If you were to search the entire tree space (all possible tree) you would obviously find the best 
possible tree. However the total number of possible trees becomes very large, even with a small 
number of taxa. A data set of 50 taxa contains roughly 2,75 x 1076 possible tree topologies. 
Therefore, to conduct an exhaustive search through the entire tree space is usually impossible 
due to the obvious time constraints. Heuristic search methods have been developed in order to 
overcome this problem. The most widely used heuristic search algorithms today in modern 
phylogenetic are the Nearest Neighbor Interchange (NNI) or the Subtree Pruning and Regrafting 
(SPR) methods. 
 
The NNI search algorithm allows for the swapping of two adjacent branches on the tree 
topology and retesting to establish if the new tree is a better fit. This is done by the elimination 
of one of the internal branches and reconnecting the taxa or clusters by the addition of another 
branch in a different place. Conversely, the more widely used SPR algorithm selects and 
removes a small subtree from the main tree topology and reinserts it elsewhere on the tree to 
create a new node on the tree. These heuristic search algorithms allow for random jumps in the 
tree space, which prevents the tree topologies getting stuck on a local maximum (which is not 
the true global maximum in the tree space). Additionally heuristics, such as NNI and SPR, 
greatly speed up the inference of phylogenies when compared to the alternative exhaustive 
search algorithms. 
1.5. Application of HIV-1 phylogenetic analysis in modern research 	  
With the advent of rapid and inexpensive DNA sequencing and the development of 
bioinformatics tools for comparing the genetic sequences from different organisms, we are now 
in the era of molecular phylogeny. Recent studies utilizing new sequencing technologies and 
genomics tools have begun to reveal a vast amount of data regarding the genetics of both HIV 
and the human immune system138-140. Today, phylogenetic analysis has become a common 
practice of many HIV/AIDS research programs, due mainly to the many insights these analyses 
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can provide and the novel questions they can address over a variety of topics related to HIV 
biology. Accurate phylogenetic inference is integral to properly understanding how 
evolutionary processes have shaped living organisms and their genomes.  
 
In the context of infectious diseases, a phylogenetic perspective can also be particularly helpful 
for drawing important medical, epidemiological, and forensic conclusions. For example, 
phylogenetic analysis of HIV-1 has been used to determine the impact of antiretroviral therapy 
(ART) on viral evolution141, 142, to infer migration patterns across broad geographic ranges and 
time-scales143, 144, and to understand transmission dynamics in populations with narrow 
geographic and temporal bounds56, 145-147. The application of phylogenetic methods to identify 
individuals who are probable sources of infection within small transmission clusters has been 
found to ‘‘meet the judicial standards of evidence admissibility’’ and the results have been 
presented as supporting evidence in courts of law119, 148. Due to the uncertainty in infection time, 
evolutionary rate and potential contacts, it is generally not possible to reconstruct the exact 
transmission network from a phylogenetic tree alone. However patients sharing similar viruses 
are potentially epidemiologically linked, so local outbreaks within the larger epidemic can be 
identified by finding transmission clusters. 
1.6. HIV-1 transmission cluster analysis and its shortcomings 
Clusters in epidemiology are broadly described as an unusual aggregation of infection, 
perceived to be greater than that expected by chance. In transmission networks, clusters are 
quantitatively defined as a group of nodes having a local clustering coefficient significantly 
greater than that of a random graph with the same number of vertices and the same mean 
shortest path149. In a phylogenetic tree, clusters contain sequences from different patients which 
share a recent common ancestor. These clusters are manifest as groupings in the phylogenetic 
tree in which we have high confidence and which are likely to reflect recent or ongoing 
transmission. However, defining and detecting meaningful transmission clusters from a 
population sample in a phylogenetic tree is not straightforward, and various strategies have been 
proposed and used in the literature. 
As shown in Figure 8, clusters are often defined based on high support (bootstrap or posterior 
probability) and/or low within cluster genetic distance, but the thresholds for both vary. The 
numbers next to each node, in pink, present a measure of support for the node. These are 
generally numbers between 0 and 1, where 1 represents maximal support. For HIV, bootstraps 
ranging from 70% and up to 99% have been used35, 47, 150-153, in combination with within-cluster 
genetic distances from 1% to 4.5% substitutions per site39, 47, 152-155. Thus a drawback of this 
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procedure is that there is an onus on the user to determine the appropriate support/distance 
thresholds and rationale for threshold selection is rarely provided; however, these decisions may 
affect study inferences. Robinson et al. enumerated this in a study where they simulated HIV 
spread and pathogen phylogenies on two different network topologies. They showed that 
threshold choices affect the size and distribution of phylogenetic clusters obtained156.  
 
Figure 8: Phylogenetic tree showing evolutionary relationships and clustering between a set of viruses. 
The blue circles represent ancestors, which in this context, mean an infected host at sometime in the past 
that in turn infected 2 or more new hosts producing chains of infections that lead to the sampled viruses 
(green circles). The branches then represent this chain of infections 157. 
The method for calculating within cluster genetic distance also varies: the mean of the pairwise 
genetic distances of clustered sequences has been employed35, as well as their median158. In 
addition to being data and user-specific, threshold values can also be affected by the statistical 
approach used to measure support. Namely, in a formal investigation conducted by Alfaro et 
al.159, the result of the phylogenetic tree branch support assessment was dependent on the 
method chosen, posterior probabilities were higher than their corresponding bootstrap values on 
average. Furthermore, reconstructing phylogenetic trees can be computationally intensive, 
especially when a large number of sequences are being considered.  Another alternative is 
“single linkage”, where a sequence is included in a cluster if its distance to just one other 
sequence in the cluster is below the threshold160, 161. If time resolved trees are used (which 
require knowledge or inference of a molecular clock), clusters can be defined based on time to 
most recent common ancestor33. These most resemble clusters generated using maximum 
genetic distance in a non-time resolved distance-based tree. Table 2 shows the lack of 
standardization of phylogenetic methods amongst HIV-1 transmission clustering analysis 
studies. There appears to be no consensus with regards to target gene selection, sequence length, 
sampling density and HIV-1 transmission cluster definition. 
37	  
Table 2: Convenient sample of HIV-1  clustering analysis studies 
Authors  Location Sample 
Size       
Sequence 
used 
Method of 
phylogeny 
reconstruction 
 HIV-1 cluster definition 
Antonia
dou et 
al.162 
Greece 98 Pol NJ ≥85% bootstrap, ≤0.015 mean intra-
cluster genetic distance 
Bezeme
r et 
al.163 
Kenya 674 Pol ML, Bayesian ≥70% bootstrap, ≤0.015 mean intra-
cluster genetic distance 
Ruelle 
et al.164 
Belgium 55 RT ML, Bayesian ≥0.89 posterior probability 
Frentz 
et al.165 
Europe, 
Israel 
4260 Pol ML ≥98% bootstrap, ≤0.030 mean intra-
cluster genetic distance 
Dennis 
et al.166 
El 
Salvador 
119 Pol Bayesian Posterior probability=1, ≤0.015 mean 
intra-cluster genetic distance 
Li et 
al.167 
China 253 Gag and 
Pol 
ML ≥70% bootstrap 
Yebra 
et al.168 
Spain 1293 Pol Bayesian ≥90 posterior probability, cluster depth 
cutoff 
Ng et 
al.169 
Malaysia 496 Pol and 
RT 
ML, Bayesian ≥2 individuals from same geographic 
location, >90% bootstrap, posterior 
probability=1 
Feng et 
al.138 
China 75 Near full 
length 
genome 
ML ≥90% bootstrap 
Siljic et 
al.170 
Serbia 221 Pol ML, Bayesian ≥90% bootstrap, ≤0.015 mean intra-
cluster genetic distance, ≥0.9 posterior 
probability 
Yebra 
et al.171 
Spain 278 Pol ML, Bayesian ≥95% bootstrap, ≥0.95 posterior 
probability 
Murrill
o et 
al.172 
Central 
America 
625 Pol ML Shimodaira-Hasegawa test (p-value 
<0.01), patristic distance threshold (25th 
percentile) 
Temere
anca et 
al.173 
Romania 61 Pol ML ≤0.01 maximum intra-cluster genetic 
distance 
Audelin 
et al.174 
Denmark 1515 Partial pol NJ, Bayesian ≥90 % bootstrap, ≤0.025/ ≤0.050 
mean/maximum intra-cluster genetic 
distance, posterior probability=1 
Chen et 
al.175 
China 308 Partial gag 
and env 
Neighbor-
joining 
≥70% bootstrap 
Han et 
al.176 
China 583 1.0-kb 
prot-RT 
Neighbor-
joining 
≥70% bootstrap 
Ivanov 
et al.177 
Bulgaria 125 Pol ML, Bayesian ≥96 % bootstrap, ≤0.10 maximum intra-
cluster genetic distance, ≥0.97 posterior 
probability 
Avidor 
et al.178 
Israel 318 Prot and 
RT 
Bayesian ≥0.95 posterior probability 
Ndiaye 
et al.179 
Senegal 109 Pol, gag 
and env 
ML ≥98% bootstrap 
Tramut
o et 
al.180 
Sicily 155 Pol ML ≥75% bootstrap 
NJ=Neighbor-joining, ML=Maximum Likelihood, RT=Reverse Transcriptase, Prot=Protease, 
Pol=Polymerase, Env=Envelope, Gag=Group-specific antigen. Adapted from181. 
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Phylogenetic clusters have been used to provide crucial insights about the spread and 
transmission of the disease37, 152, 182-185. In the case of HIV, analyses of phylogenetic clusters 
have been used to identify correlates of transmission including risk group39, stage of infection33, 
48, cluster size184, the presence or absence of co-infections, including other sexually transmitted 
infections152 as well as drug treatment and compliance. A recent study used a phylogenetic 
approach to determine the relative contribution of each of these variables to the risk of onward 
transmission186, finding that antiretroviral treatment decreased HIV transmission risk. 
The origin and geographic expansion of HIV-1 have been well characterized using phylogenetic 
approaches187, but it has been argued that these methods are suboptimal for describing recent 
HIV transmission. Wertheim et al. contended that phylogenies are well suited for differentiating 
distinct viral lineages but not for identifying transmission partners46. Several authors have 
concluded that phylogenetic analysis is most powerful at excluding potential transmission 
partners, rather than establishing linkage115, 119, 148, 188, 189. Although there are a number of 
programs available for clustering nucleotide sequences (e.g., BLASTClust190, UPGMA and 
WPGMA191, neighbor-joining (NJ)133, and phyclust192), phylogenetic approaches have been 
ubiquitous in the literature involving HIV-1 transmission clusters.  
As studies investigating HIV transmission clusters typically begin by inferring a phylogeny and 
then identifying those clades (sub-trees) that have appropriate statistical support, Wertheim et 
al. argued that this identification alone is insufficient for epidemiological purposes, because 
such an analysis lacks the concept of recency46. Additionally, high statistical support (e.g., 
bootstrap) for any specific clade indicates that there is no close relative to the clade in question, 
not that the members of the clade itself are necessarily closely related to each other193. Another 
documented problem with using phylogenetic methods to infer transmission clusters is that 
often only a single geographic region is considered, and the data must be subsampled for 
computational tractability33, 39, 43, 194-196. Both of these simplifications can seriously bias the 
interpretation due to the limited scope of the analysis, as closely related or relevant sequences 
may be inadvertently excluded during sequence selection. Also, most transmissions from one 
individual to another involve transmission of a minor variant from the circulation of the donor; 
this makes inference of transmission pairs via phylogeny difficult to impossible197. 
 
Despite these shortcomings, the best method of identifying and establishing transmission events 
of HIV between individuals or within a community is through the use of high-resolution 
phylogenetic methods of HIV sequence data198-200. Phylogenetic analysis has greatly improved 
our understanding of the epidemic, and remains at the forefront of cluster analysis on HIV 
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sequences, however there is great space for improvement. Thus the importance of the detection 
and evaluation of the parameters that effect viral clustering as this will inform the design for 
better methodologies for HIV phylogenetic cluster analysis. 
1.7. Factors that may influence the outcomes of viral clustering 	  
Phylogenetic analysis can be very informative, but the accuracy of phylogenetic conclusions is 
highly dependent on the method chosen and sampling strategy. Besides the inherent issues 
about model selection and phylogenetic inference, data availability also plays a major role. 
Some of the concerns are related to the direction of transmission or who infected whom, 
availability of all involved sexual contacts, and interpretation of the phylogeny given that 
certain individuals could be infected with more than one strain. Similarly, criminal cases of HIV 
transmission that rely solely on phylogenetic evidence are precarious. Issues of convergent 
evolution can also erroneously link individuals in the absence of any other independent source 
of evidence201.  
 
Table 3 shows research that has probed the parameters that may affect the outcome of viral 
clustering; these include certain biological processes202, sampling density203, sequence 
properties58, sequence length58 and target gene selection35, 57. A common limitation amongst 
previous research conducted is sample size and the predominant utilization of HIV-1 
polymerase datasets. Another commonality is the conclusion that the use of HIV-1 full-length 
genome sequences results in the best phylogeny for cluster enumeration; however, none have 
fully probed the optimal sequence length when full-length genome sequences aren’t feasible. 
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Table 3: Papers exploring parameters that may affect the outcomes of HIV-1 phylogenetic 
clustering 
Authors Parameter Results Conclusions 
Doyle et 
al.202 
Biological 
processes 
Convergent evolution and high rates of 
insertions and deletions (causing 
alignment uncertainty) lead to 
spurious phylogenetic signal with 
forensic relevance. 
 
Full-genome sequencing of 
HIV-1, combined with careful 
phylogenetic analyses based on 
biologically realistic models of 
sequence evolution, will greatly 
increase the information 
available for inference of 
transmission histories while 
avoiding many of the biases 
inherent to individual genes. 
 
Novitsky 
et al.203 
Sampling density HIV clustering increased linearly at 
sampling density > 10%, and was 
accompanied by narrowing confidence 
intervals. HIV clustering increased 
linearly at sampling density > 10%, and 
was accompanied by narrowing 
confidence intervals. 
The detectability of HIV clusters 
is substantially affected by 
sampling density. A minimal 
genotyping density of 10% and 
sampling density of 50–70% are 
suggested for HIV-1 V1C5 
cluster analysis. 
 
Novitsky 
et al.58 
Sequence 
properties 
Found a moderate association between 
the number of variable and informative 
sites and the proportion 
of HIV sequences in clusters 
 
Use sequences with adequate 
number of variable and 
informative sites. 
Harris et 
al.57 
Target gene 
selection 
A cluster of HIV-1 sequences from 
Ethiopia, observed in full genome 
analysis, is not sustained in sub-genomic 
regions. 
 
Results elucidate the advantages 
of the usage of near full-length 
genome sequences for cluster 
analysis. 
Novitsky 
et al.58 
Sequence length The near full-length genome HIV 
sequences showed the highest extent of 
HIV clustering and the highest tree 
certainty. Found a strong association 
between the sequence length and 
proportion of HIV sequences in clusters 
 
Near full-length genome 
sequences could provide the 
most informative HIV cluster 
analysis; selected subgenomic 
regions with a high extent 
of HIV clustering and high tree 
certainty could also be 
considered as a second choice. 
 
Hue et 
al.35 
Target gene 
selection 
The topology of the pol tree was 
consistent after exclusion of the drug 
resistance associated codons. Identical 
topologies were obtained in tress 
implemented from gag and env gene 
alignments. 
 
Despite its genetic conservation, 
the HIV-1 pol gene holds 
sufficient variability to permit 
the phylogenetic reconstruction 
of transmissions, when 
compared to the env and gag 
genes. 
Gifford 
et al.204 
 
Target gene 
selection 
Due to the presence of recombinant 
strains, the internal topologies of 
phylogenies differ depending on which 
sub-genomic region is analyzed.  
Results advocate the usage of 
full-length HIV-1 genome 
sequences for cluster analysis. 
Robinson 
et al.156 
Transmission 
cluster 
definition/threshold 
selection 
Threshold choices affect the size and 
distribution of phylogenetic clusters 
obtained. 
 
Rationale for threshold selection 
should be provided. 
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1.7.1. Target gene selection and sequence length 	  
 Genetic marker choice is important when seeking to capture transmission and other desired 
signals. Extensive debate exists concerning the gene(s) choice in HIV phylogenetics183 as they 
are a number of factors to be considered (Table 4). The pol gene has been suggested as a 
candidate due to the large dataset of HIV-1 pol sequences available, however some researchers 
have been reluctant to use it given the number of drug resistance mutations associated with this 
region. The env gene is sometimes preferable relative to the pol gene on the basis of high 
genetic variability. This was highlighted by a study done by Frange et al., 2008205, who 
analyzed 15 samples whose subtype/CRF could not be identified using RT sequences. By using 
env sequences, 6 were found to be divergent A, 2 were distantly related to E or D, 2 C, 1 B; the 
variability of env was paramount for this investigation. However, indications of convergent 
evolution on the env region can preclude its use since it violates the unique evolutionary history 
assumption made by phylogenetic methods. 
 
Table 4: Characteristics of target genes for phylogenetic analysis 
 
With the conundrum of gene target selection in mind, Lemey et al., 2005206 explored across the 
length of full-genome sequences for phylogenetic support of HIV-1 transmission events. They 
investigated three known and distinct transmission cases for which full-genome sequence data 
was available. To evaluate which genome regions are the most informative for transmission 
chain reconstruction, they performed a sliding window analysis using the same maximum 
likelihood method for different window sizes.  
 
Target 
gene 
Region Advantages Disadvantages 
env  • Codes for the external 
glycoproteins gp120 and 
gp41; contains high 
variable regions including 
v3 loop 
• High number of 
sequences available 
in genetic 
databases 
• High variability 
• Can lead to convergent 
evolution whereby two 
sequences are similar 
because of homoplasy, not 
homology 
 
gag • Codes for internal virion 
proteins 
• Less variable target 
than env 
• Fewer database sequences 
than env and pol 
 
pol • Codes for the enzymes 
reverse transcriptase, 
protease and integrase 
• Least variable 
• Highest number of 
sequences in 
genetic databases 
• May be argued its too 
conserved to contain useful 
phylogenetic information 
• Sight of drug resistance 
mutations 
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For a window size of 400 nucleotides, only the vif gene region provided considerable bootstrap 
support (> 90%) for all three transmission clusters. More importantly, extensive variation in 
gene-specific bootstrap support was observed among the three transmission chains. Increasing 
the window size up to 800 nucleotides resulted, on average, in an increase in transmission 
cluster support and more distinct patterns of gene-specific support. The 3’ part of the pol gene 
up to the env gene appeared to provide relatively good support for all three transmission 
clusters. However, there was still considerable variability in transmission cluster bootstrap 
support for gag and env. A window size of 1200 nucleotides resulted in a further average 
increase in bootstrap support but still showed the gag and env differences. They concluded that 
transmission chain support across the genome can be case specific and it does not appear to be 
largely moderated by functional constraints across the genome. Harris et al. also argued that 
phylogenetic relationships determined with partial genomes may not be reproduced when other 
regions of the genome are considered57. 
 
Controversy has been expressed on the adequacy of single gene phylogenies to establish 
confidently true relationships in transmission cases207, 208. The initial analysis by Sturmer et al.209 
of the pol and env regions in strains derived from the two case patients and several controls, 
both local and from the databases, led the authors to conclude that the pol sequence on its own 
did not provide enough information to clarify the relationship between the two patients. Hue et 
al.35  came to the conclusion that ‘there is no such thing as an ultimate gene for evolutionary 
analyses of HIV-1 and, ideally, full-length sequences should be used’. 
1.7.2. Contrasting the usage of full genome and sub-genomic sequences for HIV-1 
cluster analysis 
 
To improve the methodology of HIV cluster analysis, Novitsky et al. investigated the influence 
of the usage full genome versus sub-genomic sequences. Their analyses indicated that near full-
length genome HIV sequences showed the highest extent of HIV clustering and the highest tree 
certainty. They concluded that near full-length genome sequences could provide the most 
informative HIV cluster analysis58.  To highlight the shortfalls of using sub-genomic data, 
Harris et al. showed that a cluster of HIV-1C sequences from Ethiopia, observed in full genome 
analysis, was not sustained in sub-genomic regions57. 
 
One of the key advantages of full HIV-1 genome analysis is thorough subtype classification, 
which, after taking appropriate consideration for the exclusion of recombination events taking 
place during amplification, can then allow the examination of complex recombination events 
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occurring in vivo. Such recombination events can be observed within sequences from different 
compartments within a single individual, from different individuals with the same subtype, or 
from different subtypes210, 211.  Full HIV-1 genome analysis provides robust information for 
investigations of HIV-1 recombination. Yamaguchi et al.212 noted that HIV-1 strain 
classification based on partial genome fragments has limitations and recombinant strains may 
go unrecognized in the absence of complete genome sequences. With the use of full genome 
sequencing, they were able to identify one circulating recombinant form (CRF) and six unique 
recombinant forms (URF) in the Saudi Arabian population.  The benefits of complete versus 
targeted sequencing are numerous and include characterization of the complete genome 
allowing for identification of accessory / compensatory mutation and detection of rare genetic 
variants 213-215. 
 
Analysis done by Gifford et al.204 also shows how phylogenies inferred from sub-genomic 
regions can be spurious. They conducted a strain-level classification of HIV-1 genetic diversity 
using 976 complete-genome sequences (Figure 9). The phylogenetic trees depicted here 
illustrate that due to the presence of recombinant strains, the internal topologies of phylogenies 
(shown as dotted lines) differ depending on which sub-genomic region is analyzed. Thus, the 
CRF03 strain illustrated, highlighted in trees by shaded circles, can be seen to group with 
subtype A in trees constructed using gag (A) and with subtype B in trees constructed using pol 
(B).  
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Figure 9: Neighbour-joining (NJ) phylogenies constructed using sub-genomic regions a) gag and b) pol. 
CRF03 AB groups with subtype A in the gag phylogeny and subtype B in the pol phylogeny204. 
For transmission cluster analysis in the present study, we utilized PhyloPart, a relatively novel 
software tool for large-scale phylogeny partition158. This method is based on a depth-first search 
algorithm and conjugates the evaluation of node reliability, tree topology and patristic distance 
analysis. Other available methods have used different cluster selection schemes by performing 
nested phylogenetic analyses, and/or adding criteria for geographical consistency39, 47, 154, 184, 186, 
194 but in most cases the assessment of transmission clusters is still subject to a visual tree 
inspection. The definition of a transmission cluster proposed in this method is general and can 
be tuned to accommodate any of the previous definitions, making it an ideal tool to explore 
parameters that may influence viral clustering outcomes. 
 
We also utilized a novel phylotype-based exploratory tool that has the ability to use phylogenies 
constructed with any of the most popular methods, while providing fast inference of ancestral 
traits and enabling hypothesis testing and visual data interpretation of evolutionary scenarios. 
The method combines ancestral trait reconstruction using parsimony, with combinatorial and 
numerical criteria measuring tree shape characteristics and the diversity and separation of the 
potential phylotypes216. 
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1.8. Assessing the accuracy of phylogentic trees 
 
In assessing which gene target or sequence length is optimal for phylogenetic cluster analysis, 
an important step is contrasting the accuracy of phylogenies inferred from each gene fragment 
and sequence length. Four principal methods have been used for assessing phylogenetic tree 
accuracy in HIV-1 clustering analysis studies: simulaton, known phylogenies, statistical 
analyses, and congruence. Simulations are useful for studying accuracy of methods under 
idealized conditions and can be used to make general predictions about the behaviour of 
methods if the limitations of the models are taken into account. Yebra et al. recently used this 
method to determine which gene(s) provide(s) the best approximation to the real phylogeny by 
sub-sampling a simulated dataset of 4662 sequences217. Although the sample size was 
significant, many biological systematists dismiss simulation results because there is usually a 
complete fit between the evolutionary model used to simulate the sequence data and the model 
used for analysing it. 
 
Studies of known phylogenies can also be used to test predictions from simulation studies, thus 
providing a check on the robustness of the models. This was a methodology utilized by Leitner 
et al. where they constructed a true phylogenetic tree based on he knowledge about when the 
transmissions had occurred and when the samples were obtained56. This complex, known HIV-1 
transmission history was then compared with reconstructed molecular trees, which were 
calculated from the DNA sequences by several commonly used phylogenetic inference methods 
[Fitch-Margoliash, neighbor-joining, minimum-evolution, maximum-likelihood, maximum-
parsimony, unweighted pair group method using arithmetic averages (UPGMA), and a Fitch-
Margoliash method assuming a molecular clock (KITSCH)]. A drawback of the utilization of 
known phylogenies is the data required for the complex reconstruction of the true tree. An 
alternative method for phylogeny accuracy assessment is statistical analysis. Statistical analyses 
allow general predictions to be applied to specific results, facilitate assesments as to whether or 
not sufficient data have been collected to formulate a robust conclusion, and indicate whether a 
given data set is any more structured than random noise. Finally, congruence analyses of 
muliple data sets can be used to assess the degree to which independent results agree and thus 
the minimum proportion of the that can be atrributed to an underlying phylogeny. 
1.8.1. Tree branch support assessment 
1.8.1.1. Tree certainty 
Computing and evaluating tree branch supports (measures of confidence in given branches) are 
indispensable parts of phylogenetic inference. In particular, support measures are crucial to 
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validating or refuting biological hypotheses on the basis of trees218. Parallel to the development 
of phylogenetic inference methods, various measures of branch support have been proposed. In 
the statistical paradigm, the perhaps three most desirable properties of a branch support measure 
are high accuracy, power, and robustness. High accuracy implies that under the true model, 
incorrectly inferred branches should not be statistically supported. High power implies that 
correctly inferred branches should have high statistical support. As for high robustness, it 
conveys the notion that modeling inadequacies, which are unavoidable when dealing with real 
biological data, do not strongly affect the accuracy of the measure. 
 
In the present study, the accuracy of each inferred phylogeny was assessed by estimating 
phylogenetic tree certainty. This calculation is based on a set of novel measures proposed by 
Salichos and Rokas for quantifying the confidence for bipartitions in a phylogenetic tree219. 
These measures are the so-called Internode Certainty (IC) and Tree Certainty (TC), which are 
calculated for a specific reference tree given a collection of other trees with the exact same 
taxon set. The underlying idea of IC is to assess the degree of conflict of each internal branch (a 
branch connecting two internal nodes) of a phylogenetic reference tree by calculating Shannon’s 
Measure of Entropy220. This score is evaluated for each bipartition in the reference tree 
independently. The basis for the calculations is the frequency of occurrence of this bipartition 
and the frequencies of occurrences of a set of conflicting bipartitions from the collection of 
trees. In contrast to classical scoring schemes for the branches, such as simple bipartition 
support or posterior probabilities, the IC score also reflects to which degree the most favoured 
bipartition is contested.  
 
1.8.1.2. Bootstrapping and approximate likelihood ratio tests 
 
To probe phylogenetic tree accuracy, bootstrapping can be done to infer the reliability of branch 
order. Bootstrap resampling as a statistical tool was invented in the late 1970’s by Bradley 
Efron221 and was introduced into the field of molecular phylogenetics by Joseph Felsenstein in 
the mid 1980’s222. Briefly, bootstrapping in modern molecular phylogenetics entails continuous 
resampling of taxa, over a user specified number of iterations (Figure 10). Following the 
resampling statistical confidence for branches are obtained by a single value. Therefore, a 
bootstrap value of 70 for a branch indicates that in 70% of the resampled cases, the taxa that are 
joined by the internal node of that branch clustered together. Bootstrapping does not resolve the 
question of whether the tree topology that was obtained is the best possible fit for the given data 
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set. It only provides a degree of confidence estimation for the internal branching order of the 
topology. 
 
 
 
 
Figure 10: Diagrammatical depiction of bootstrap analysis. A neighbour joining tree is (red box) is 
inferred from the input alignment (purple box). Columns on the input alignment are then randomly 
sampled (green boxes) and a tree is inferred. This sampling-inference process is repeated – usually 1000 
times. Branches on the correct tree are compared to branches on the trees from the random samples 
(circle) 16. 
Despite the popularity of nonparametric bootstrap frequencies and Bayesian posterior 
probabilities, the interpretation of these measures of tree branch support remains a source of 
discussion223. Furthermore, both methods are computationally expensive and become 
prohibitive for large data sets. Recent fast approximate likelihood-based measures of branch 
supports (approximate likelihood ratio test [aLRT] and Shimodaira–Hasegawa [SH]-aLRT) 
provide a compelling alternative to these slower conventional methods, offering not only speed 
advantages but also excellent levels of accuracy and power223. SH-aLRT was developed and 
implemented in the PHYML phylogenetic inference software223. It is derived from the SH 
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multiple tree comparison procedure224 and is fast due to the RELL technique based on the 
resampling of estimated log likelihoods225. 
1.9.2. Tree metrics 
 
In this study, we evaluated the cluster quality in inferred phylogenies by using phylogenetic tree 
metrics that quantitatively measure the extent of strain clustering. The tree metrics include two 
statistics that are used to quantify the degree of clustering present on the tree topology. The 
subtype diversity ratio (Figure 11, Panel A), SDR, is defined as the ratio of the mean intra-
cluster pairwise distance to the mean inter-cluster pairwise distance226. The SDR is therefore a 
quantitative measure of the extent of clustering found within a tree. Low intra-cluster pairwise 
distances relative to inter-cluster pairwise distances implies more defined clustering in the tree. 
Thus trees with lower SDR values are characterized by well defined clusters. An SDR 
approaching one would indicate a lack of clustering is present in the tree. As the SDR does not 
take into account the variability that can occur between individual clusters the subtype diversity 
variance (Figure 11, Panel B), SDV, was devised. The SDV statistic is a measure of the 
variation within the ratio of the mean intra-cluster pairwise distance to the mean inter-cluster 
pairwise distance calculated for each cluster on the tree. The lower the SDV value the more 
symmetrical, or equidistant, the clusters in a tree are relative to each other. 
 
 
 
Figure 11: Subtype diversity ratio and subtype diversity variance. (A) The relationship between the SDR 
and the quality of clustering on a phylogenetic tree (B) The relationship between the SDR and the 
variability of the quality of clustering16. 
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In the present study, not only were the outcomes of HIV-1 clustering probed, but also the 
accuracy of the inferred phylogenies from which clustering analysis was done. This is 
significant as the accuracy of the outcomes of viral clustering, that is, the proportion of 
sequences in clusters enumerated, is dependent on the quality of the reconstructed phylogenetic 
tree. 
 
Aims 
 
1. To determine if the usage of full-genome sequence data as opposed to sub-genomic data 
for phylogenetic tree construction results in a more accurate phylogenetic tree, 
measurable by tree certainty; subtype diversity ratio; subtype diversity variance; and 
Shimodaira-Hasegawa-like support values. 
2. To elucidate the optimal window size (sequence length) and genomic region to 
accurately identify transmission clusters. 
Objectives    
 
1. To sequence the full-length of subtype C HIV-1 genomes using next generation 
sequencing platform (Illumina Miseq). 
2. To reconstruct HIV phylogenies using different sub-genomic sequences and sequence 
lengths. 
3. To evaluate and contrast the outcomes of viral clustering and phylogeny accuracy per 
parameter investigated. 
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CHAPTER TWO: METHODOLOGY 
 
The methodology that was used during the course of this study will be discussed in this chapter. 
This project involved five main steps: (1) the retrieval of HIV-1 full genome sequences from the 
LANL Database and the generation of full genome sequences from patient samples, (2) the 
stratification of data per parameter investigated, (3) the inferring of phylogenies from different 
sequence lengths and sub-genomic regions, (4) the phylogeny accuracy assessment and 
clustering analysis for each phylogeny, and (5) the interpretation of the analyzed data. 
 
Briefly, the general aim was to improve the methodology of HIV cluster analysis by addressing 
how analysis of HIV clustering is associated with parameters that can affect the outcome of 
viral clustering. The extent of HIV clustering, tree certainty, subtype diversity ratio, subtype 
diversity variance and Shimodaira-Hasegawa-like support values were compared between 2881 
HIV-1 full genome sequences and sub-genomic regions of which 2567 were retrieved from the 
LANL HIV Database and 314 were sequenced from blood samples from a cohort in KwaZulu-
Natal. Sliding window analysis was based on 99 windows of 1000 bp, 45 windows of 2000 bp 
and 27 windows of 3000bp. Clusters were enumerated for each window sequence length, and 
the optimal sequence length for cluster identification was probed. Potential associations 
between the extent of HIV clustering and sequence length were also evaluated. 
2.1. Ethics statement 
 
This study was approved by the Biomedical Research Ethics committee of the University of 
KwaZulu Natal (ref. BF052/10), the Health Research Ethics committee of the KwaZulu Natal 
Department of Health (ref. HRKM 176/10) and all study participants provided written informed 
consent for the collection of samples and subsequent analyses. The investigations also comply 
with the South Africa National Health Act No 612003 and abide by the ethical norms and 
principles for research as established by the Declaration of Helsinki, the South African Medical 
Research Council Guidelines as well as the Department of Health Guidelines. 
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2.2. Reagents and equipment 
 
All the reagents, equipment, and software applications that were used during the course of this 
study are listed in Table(s) 5 - 7. All chemical and biological agents or commercial kits that 
were used in this study are summarized in Table 5. 
 
Table 5: List of chemicals and commercial products used in the study 
Chemical or Commercial products and kits used Suppplying Company 
QIAamp Viral RNA Mini kit  QIAGEN 
SuperScriptIII One-Step RT-PCR system Invitrogen 
Taq DNA Hgh Fidelity Polymerase Invitrogen 
dNTP's Invitrogen 
Nuclease free water Invitrogen 
Ethidium Bromide Invitrogen 
Agarose Whitehead Scientific (Pty) Ltd 
Novel Juice 6x Whitehead Scientific (Pty) Ltd 
QIAquick PCR Purification Kit QIAGEN 
Nextera XT DNA Sample Preparation Kit Illumina 
Nextera PCR Master Mix (NPM)  Illumina 
AMPure XP beads Illumina 
Resuspension buffer (RSB) Illumina 
 
A brief summary of all the equipment that was used during the course of this study is listed in 
Table 6. 
 
Table 6: Equipment used to perform sample analysis 
Piece of Equipment Supplying Company 
QIAcube nucleic acid isolation system QIAGEN 
GeneAmp PCR System 9700 thermal cycler Applied BioSystems 
Qubit flourometer Qubit 
Illumina Miseq Sequencer Illumina 
 
The various software applications, and/or, online analytical tool that were used during the 
phylogenetic analysis of the sequence data are listed in Table 7. 
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Table 7: Software programs and online analytical tools that were used in the analysis of sequence 
information 
Software package Reference and/or licensed companies 
ClustalW Thompson et al227 
FigTree ver 1.3.1 Rambaut (http://tree.bio.ed.ac.uk) 
FastTree v2.1.4 Price et al228 
cTree Archer et al229 
RAxML ver. 8.2.9 Stamatakis131 
PhyloPart ver. 2.1 Ragonnet-Cronin et al230 
PhyloPart StandAlone PST07 Chevenet et al231 
Geneious ver 8 Biomatters Ltd 
Anaconda Python ver 2.7 Python232 
Se-al ver. 2.0  Rambaut233 
 
2.3. HIV-1 full-genome sequences 
2.3.1. Full-genome sequences from the LANL HIV Database 
 
A set of 2567 HIV-1 full-genome sequences was retrieved from the LANL HIV Database 
(www.hiv.lanl.gov/). The set of 2567 HIV-1 full-genome sequences included 7 HIV-1 subtypes 
(A to D, F to H), sub-subtypes and circulating recombinant forms.  
2.3.2.  Full-genome HIV-1 sequences from a South African cohort 
 
To supplement the data retrieved from the LANL HIV database, 314 full-genome sequences 
were sequenced from blood samples obtained from residents of Hlabisa, a predominantly rural 
sub-district within the uMkhanyakhude District of northern KwaZulu-Natal (Figure 12), with a 
population of 228 000. This area formed a cohort that included HIV-infected people enrolled at 
17 primary health care facilities served by a single district hospital. The local district hospital 
(Hlabisa) has 296 beds. Six of the Department of Health clinics, and 40% of patients, fall within 
the Africa Centre Demographic Surveillance Area (DSA), which has a population of 85 000 
people in a 438-km2 area. The DSA population is well characterized234. Information on these 
individuals is collected within the Africa Centre Demographic Information System (ACDIS) 
and a random 12.5% are tracked each year for the HIV surveillance, allowing a more complete 
understanding of the determinants of HIV infection235.  
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Figure 12: Hlabisa sub-district, northern KwaZulu-Natal, showing position of primary hospital with one 
on-site clinic and 15 peripheral clinics. Location of the Africa Centre is also shown. The Hlabisa sub-
district extends to the area at the bottom-right of the map to encompass Zwelisha and Mtubatuba 
clinics236. 
2.3.2.1. Sample collection, transport and processing  
At all the 17 primary health clinics, blood specimens were collected from study participants 
using 5ml EDTA tubes. On the same day of collection, the blood samples were transported from 
the Africa Centre head office in Mtubatuba to the Africa Centre Laboratory (ACL) in Durban 
(200km away); samples were kept on ice during transportation. Samples were received at the 
ACL and subsequently recorded in the laboratory information management system. The blood 
plasma was isolated, aliquoted and stored at -80°C. 
 
2.3.2.2. RNA extraction 
HIV-1 RNA was extracted using a QIAamp Viral RNA Mini kit (Qiagen NV, Venlo, 
Netherlands). The protocol as per the manufacturer’s guidelines was modified to extract RNA 
from 200µl of plasma instead of from 140µl of plasma; this was done to provide adequate viral 
RNA needed for full genome sequencing237. The stored plasma was retrieved, thawed and 
centrifuged at a speed of 13 000 x g for 1 hour to concentrate the viral RNA. 200µl of plasma 
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was added to 800µl of lysis buffer, and was incubated for 10 minutes. 800µl of absolute ethanol 
was added to precipitate the RNA. The mixture was then loaded into the spin column, and 
centrifuged at 13 000 x g for 1 minute, to allow the extracted viral RNA to bind to the silica 
membrane. This step was followed by two washes with Wash Buffer 1 and Wash Buffer 2 with 
centrifugation in between the washes. After the second wash, a second dry spin was done to 
remove any excess of the washing buffer. Finally, 60µl of elution buffer was added to the 
column and RNA was eluted into a clean 1.5ml collecting tube. Eluted viral RNA was then 
stored at -80°C. 
 
2.3.2.3. Amplicon generation  
The extracted RNA was used for PCR amplification. We adapted the published protocol from 
Gall and colleagues238 for amplification, sequencing and assembly of full-length HIV-1 
genomes; the original primers pairs (Pan1, Pan2, Pan3 and Pan4) were redesigned to be HIV-1 
subtype C specific (Table 8) and were reviewed using Quick Align tool239. Four overlapping 
amplicons, covering 9.7kbp of HIV-1 genome, were generated (1.9 kbp, 3.6 kbp, 3 kbp, and 3.5 
kbp respectively) as shown in Figure 13. This was achieved by using SuperScriptIII One-Step 
RT-PCR system with Platinum Taq DNA High Fidelity polymerase (Invitrogen). For all 
samples, the reactions of the PCR assays contained 4.5µl of water, 12.5µl of 2x Reaction Buffer, 
1µl of each primer at 10µM, 1µl of SuperScriptIII One-Step RT/ Platinum Taq High fidelity mix 
and 5µl of the RNA template. The following cycling conditions were used (Table 9):	  one cycle 
of denaturation at 94°C for 4 minutes, followed by 40 cycles of denaturing at 94°C for 15 
seconds, primer annealing at 60°C for 30 seconds, primer extension at 68°C for 4 minutes 30 
seconds, one final step of primer extension at 68°C for 10 minutes, after which samples were 
cooled down and stored at 4°C. 
Table 8: Summary of the primers for NGS amplification238 
Set and primer Sequence (5'-3') Position (nucleotide) Product size (base pair) 
Pan-HIV-1_1F AGC CYG GGA GCT CTG TG 26-42 1928 
Pan-HIV-1_1R CCT CCA ATT CCY ATC ATT TT 1953-1931  
    
Pan-HIV-1_2F CGG AAG TGA YAT AGC WGG AAC 1031-1051 3574 
Pan-HIV-1_2R CTG CCA TCT GTT TTC CAT ARTC 4604-4583  
    
Pan-HIV-1_3F TTA AAA GAA AGG GGG GGA TTG GG 4329-4351 3066 
Pan-HIV-1_3R TGG CYT GTA CCG TCA GCG  7394-7377  
    
Pan-HIV-1_4F CCT ARG GCA GGA AGA AGC G 5513-5531 3551 
Pan-HIV-1_4R CTT WTA TGC AGC WTC TGA GGG 9063-9043  
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Figure 13: An illustration of the location and amplicon size of each pan primer. The overlapped primers 
span almost the full HIV genome from the 5’ to the 3’LTR. 
For samples that failed amplification using One-Step RT-PCR, the RT step was redone with 
specific reverse primers in the SuperScript III First Strand Synthesis kit to generate cDNA. 
Following that, the PlatinumTaq High Fidelity DNA Polymerase kit was used for amplification. 
Briefly, the reaction used 5µl of RNA in a 12.5µl reaction volume and resulted in a final primer 
concentration of 1.6µM. The cycling conditions for the reverse transcription step were: 65°C for 
5 minutes, a hold for 4 minutes at 4°C during the addition of the SuperScript III first strand for 
the synthesis of cDNA, followed by 30 cycles of 95°C for 30 seconds, 58°C for 20 seconds, 
72°C for 2 minutes, and a final extension at 72°C for 10 minutes. Amplicons were generated 
from 2.5µl of the cDNA in a total reaction volume of 25µl. The cycling conditions for the 
generation of amplicons were almost identical to those shown in Table 9: one cycle of 
denaturation at 94°C for 2 minutes, followed by 40 cycles of denaturing at 94°C for 15 seconds, 
primer annealing at 60°C for 30 seconds, primer extension at 68°C for 4 minutes 30 seconds, 
one final step of primer extension at 68°C for 10 minutes, after which samples were cooled 
down and stored at 4°C. Additionally, all PCR assays were run with a positive HIV-1 control 
sample that amplified well under the same conditions. 
Table 9: Master Mix for DNA amplification and PCR cycling conditions 
Reagents  Volume/sample Vol in 
MM(ul) 
Final 
Concentration 
Water  4.5 72   
2x Reaction Buffer  12.5 200 1x 
Primer mix (10µM each) 2.0 32 0.4µM 
SSIII/Platinum Taq 
polymerase (5U/l) 
1.0 16 5U 
     
   320   
Volume/sample  20.0    
RNA Sample  5.0    
  Cycling Conditions  
Temperature Duration Number of cycles  
94 2 minutes 1 
94 15 seconds 40 
60 30 seconds 40 
68 4 minutes 30 seconds 40 
68 10 minutes 1 
4 ∞ Hold 
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2.3.2.4. Gel visualization 
 
PCR products were separated on 0,8% ethidium bromide stained agarose gels (10 cm long) for 
visualization of the PCR DNA products (Figure 14). The gel was prepared by adding 0.5g of 
agarose tablet to 50ml of TBE buffer, which was followed by heating the mixture to boiling 
point. The gel was poured into a gel-casting tray containing a comb and was set for 20 to 30 
minutes. 1µl of non-mutagenic fluorescent reagent Novel Juice 6x was mixed with 4µl of PCR 
product. Mixes were then loaded into agarose gel and run at 100 Volts for 60 minutes, the PCR 
DNA products were then assessed. The DNA bands were confirmed from Pan 1 to Pan 4. 
 
Figure 14: Gel visualization of the PCR DNA products. Gel visualization of the PCR DNA products. 
Each amplicon runs at different lengths, for example 0.70 - 1 = Pan1, 2 = Pan2, 3 = Pan3 and 4 = Pan4. 
The scale of the ladder is shown on the left. 
2.3.2.5. PCR purification 
All successful generated amplicons were cleaned up using a QIAQuick PCR Purification kit 
(Qiagen)240. This began by adding 100µl of binding buffer to 20µl of each sample PCR product. 
The mixture was then transferred to the silica-column and centrifuged for 1 minute at 13 000 x 
g. 650µl of wash buffer PE was added to wash and purify the PCR product and the column was 
centrifuged for 1 minute at 13 000 x g. A dry centrifugation was then performed to remove 
possible residual of wash buffer PE. Finally the purified PCR product was eluted in 50µl of 
elution buffer after 1 minute of centrifugation at 13 000 x g. 
4000bp 2000bp	  
1000bp 
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2.3.2.6. DNA quantification  
The DNA quantification was done using Qubit fluorometer241 . This device defines 
concentrations of particles via fluorescent dyes that only bind to a particular kind of substance 
such as DNA, RNA or proteins. These dyes have a very low fluorescence before they bind to 
their target DNA, however, they fluoresce strongly after binding. Therefore, the known DNA 
standards are used to convert the fluorescence signal into DNA concentration. Samples were 
diluted to 2ng/µl and pooled in a 1:3:3:3 ratio of Pan-1 to Pan-4 respectively for a final volume 
of 10µl; the pooling of PCR products was done into equimolar amounts to create the library. 
2.3.2.7. Next generation DNA Sequencing  
The pooled library was then prepared and sequenced according to the Miseq system user guide 
instructions. Briefly, 96 samples were prepared using Nextera XT DNA Sample Preparation 
Kit; this included 2 controls (negative and intra control) and 1 sample repeat. A 96 well Nextera 
XT Tagment plate was prepared and 10µl Tagment DNA Buffer (TD) buffer was added to each 
well. This was followed by the addition of 5µl of 2ng/µl input DNA and 5µl of Amplicon 
Tagment Mix (ATM) to each well using a multichannel pipette. This allows DNA input to be 
tagmented with adapter sequences added to the end. 15µl of Nextera PCR Master Mix (NPM) 
was then added to each well. This was followed by the addition of 5µl of index 1(i7) and 5µl of 
index 2 (i5) primers to the tagmented DNA; the purpose of this is cluster formation. This was 
then amplified through a limited PCR program on a thermal cycler; Table 10 shows the PCR 
amplification cycling conditions. 
 
Table 10: Thermal cycler Nextera PCR amplification cycling conditions  
  Cycling Conditions  
Temperature Duration Number of cycles  
72 3 minutes 1 
95 30 seconds 1 
95 10 seconds 122 
55 30 seconds 122 
72 30 seconds 122 
72 5 minutes 122 
10 ∞ Hold  
 
PCR amplification was followed by purification of the library DNA via the addition of 30µl 
AMPure XP beads to each well. The beads were then washed via the addition of 200µl of 80% 
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ethanol to each well. This provides a size selection step to remove very short fragments from 
the library. 52.5µl of Resuspension Buffer (RSB) was then added to each well. We then 
transferred 50µl of the supernatant to a clean 90 well plate. 45µl of the combined Library 
Normalization Additives 1/ Library Normalization Beads1 (LNA1/LNB1) was added to each 
well containing the DNA libraries. This was followed by adding 2 x 45µl of LNW1 to each well 
to wash the beads. 30µl of 0.1 N NaOH and 30µl of Library Normalization Storage Buffer 1 
(LNS1) were added after elution. Following that, 30µl of supernatant was transferred to each 
well. Lastly, the pooled library was diluted in hybridization buffer, then loaded into a thawed 
MiSeq reagent cartridge and placed into Illumina MiSeq machine for sequencing.  
 
2.3.2.8. Assembly and consensus generation 
FastQ files generated by sequencing were imported into Geneious software version 8.0 
(Biomatters Ltd, Auckland, New Zealand), an integrated and extendable software platform for 
the organization and analysis of genomic and sequence data242. Primer sequences were removed, 
and quality control (removing reads of <200 bp and trimming low-quality bases from the 3’ end 
of the reads until the median quality of the read was <30) was performed. The remaining reads 
were trimmed (10bp from 5’ and 30bp from 3’ ends), and then assembled; this helps to decrease 
the probability of ambiguous read mapping, which occurs when shorter reads of lower accuracy 
are included in assemblies243. Full-genome contigs were generated by assembly of the trimmed 
reads against a subtype C reference sequence from SA (Accession no AY228557), to derive a 
consensus sequence. 
2.4. Multiple sequence alignment  
 
A data set of 2881 full-genome HIV-1 sequences was obtained (314 sequenced from blood 
samples combined with the 2567 sequences retrieved from the LANL HIV Database). Multiple 
alignments of the 2881 sequences, along with 7 HXB2 sub-genomic reference sequences, were 
constructed in ClustalW (http://www.clustal.org/clustal2/)244. In order to increase the speed of 
the alignment, a quick tree was employed to guide the alignments. Alignment was exported into 
Se-Al (http://www.tree.bio.ed.ac.uk/software/seal/) and was manually aligned. Gaps were 
excluded from the alignment if the gaps were not present in more than 20% of the taxa in each 
of the alignments. Sequences were manually aligned until a perfect codon alignment was 
achieved. 
 
59	  
2.5. Analyzed sub-genomic regions of the HIV-1 genome 
 
The extent of HIV clustering using near full genome sequences was compared with the 
outcomes of HIV clustering using sub-genomic sequences. To achieve this, sub-genomic 
regions were extracted from the multiple sequence alignment using the Geneious software 
platform242. These included regions spanning the three structural HIV-1 genes, gag, pol, and 
env, and four alternative sub-genomic regions that have been used or proposed for HIV cluster 
analysis, bringing the total to seven sub-genomic regions. The four alternative sub-genomic 
regions included (1) a partial pol sequence spanning the region encoding HIV-1 protease and 
the first 335 amino acids of reverse transcriptase, which corresponds to HXB2 nucleotide (nt) 
positions 2,253 - 3,554245-248; (2) partial env sequences spanning the region encoding the gp120 
V1C5 region249-251, nt positions 6,570 - 7,757; (3) “product 2” spanning the 3’ -end of gag  and 
almost the entire pol252, nt positions 1,486 - 5,058; and (4) ‘‘product 4’’ spanning vpu, env, nef, 
and TATA-box in the U3 region of 3’ -LTR, nt positions 5,967- 9,517. 
2.6. Sliding window analysis 
 
Sliding window analysis is a commonly used method for studying the properties of molecular 
sequences253. To estimate the extent of clustering across the HIV-1 genome, a sliding window 
analysis with windows advancing incrementally across the multiple sequence alignment (a 
window of a certain length slid along the sequence alignment) was employed. The data sets of 
multiple sequence alignments of different window lengths were generated using Python 
programming language, version 2.7.254. Figure 15 depicts the script that was specifically 
formulated for this analysis. Three sizes of sliding windows were used, 1000-bp, 2000-bp and 
3000-bp. Sliding steps were equal to 1/10 of the window size; 100 bp for the 1000-bp window, 
200 bp for the 2000-bp window and 300 bp for the 3000-bp window; and produced multiple sets 
of overlapping multiple sequence alignments. A total of 99 alignment sets of 1000 bp each, 45 
alignment sets of 2000 bp each and 27 alignment sets of 3000 bp were generated, resulting in 
171 sets.  
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Figure 15: Python interface showing script to generate datasets for sliding window analysis 
2.7. Phylogenetic inference 
 
The alignment sets (171 of various window lengths, 7 of HIV-1 sub-genomic regions and the 
full genome alignment) were used to infer phylogenies with the use of the Maximum likelihood 
(ML) method as implented in FastTree v2. 1. 4228. For each data set, phylogenies were inferred 
under the generalized time-reversal (GTR) model, an estimated gamma shape parameter, and 
the subtree pruning and regrafting (SPR) method of tree rearrangement. For the ML tree 
topologies, a total of 100 bootstrap replicates were performed for each data set. Inferred tree 
topologies were visually inspected in FigTree v. 1.3.1 (http://tree.bio.ed.ac.uk/software/figtree/). 
The maximum likelihood tree inference was also implemented in RAxML131 under the 
GAMMA model of rate heterogeneity for the full genome and 7 sub-genomic alignment sets. 
The statistical support for each node was assessed by bootstrap analysis from 1000 bootstrap 
replicates performed with the rapid bootstrap algorithm implemented in RAxML. The RAxML 
runs were performed using RAxML v. 8.2.9. The average time of each of the runs varied 
depending on the sequence length of each data set. The smallest data sets took on average 
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around 36 hours, while the largest took up to 10 days. Each of the runs were executed on a Mac 
OS X 10.10.5 (Yosemite) with a 2,5 GHz Intel Core i5 processor. 
2.8. Assessment of the accuracy of the inferred phylogenies 
2.8.1. Estimation of tree certainty  
 
Tree certainty quantifies the degree of conflict or incongruence in a set of phylogenetic trees219. 
The quantification of incongruence is based on Shannon’s entropy220. The internode certainty 
was measured by quantifying the degree of certainty for each individual internode by 
considering the two most prevalent conflicting bipartitions and calculating the log magnitude of 
their difference. An internode certainty close to 1 indicates high certainty of the targeted tree 
node and a lack of conflict in the data, while values of internode certainty close to 0 show a high 
degree of incongruence. Tree certainty quantifies the degree of conflict for the whole tree, and is 
the sum of internode certainty over all internodes in a phylogeny. Tree certainty scores were 
calculated in RAxML ver. 8.2.9 as described by Salichos and colleagues255. Extended majority-
rule consensus trees were computed using bootstrapped trees generated by RAxML for the full 
genome alignment and for each sub-genomic alignment set. 
2.8.2. Estimation of Shimodaira–Hasegawa [SH]-aLRT 
 
Shimodaira-Hasegawa (SH)-like support value computation was implemented in RAxML ver. 
8.2.9255 as described by Guindon and colleagues256. SH-aLRT is derived from the SH multiple 
tree comparison procedure224 and is fast due to the RELL technique based on the resampling of 
estimated log likelihoods225. The input for each run was the best-known ML phylogeny found 
by RAxML analysis. Prior to the application of the SH-like test, the requirement is that each 
tree has to be NNI (Nearest Neighbour Interchange) optimal. Thus, for the full genome and 7 
sub-genomic phylogenies, RAxML initially applied NNI moves to further improve the trees and 
then computed the SH test for all the inner branches of the trees. 
2.8.3. Evaluation of cluster quality 
 
Cluster quality was evaluated in CTree, via an executable jar file from: 
http://www.manchester.ac.uk/bioinformatics/ctree. CTree was designed for the quantification of 
clusters within viral phylogenetic tree topologies. Clusters are stored as individual data 
structures from which statistical data, such as the Subtype Diversity Ratio (SDR), Subtype 
Diversity Variance (SDV) and pairwise distances can be extracted. The SDR, is defined as the 
ratio of the mean intra cluster pairwise distance to the mean inter cluster pairwise distance257. 
62	  
Low intra pairwise distances relative to inter pairwise distances imply the presence of more 
defined clusters. The SDV is a measure of the variation within the ratio of the mean intra- 
cluster pairwise distance to the mean inter- cluster pairwise distance calculated for each cluster 
on the tree16. The lower the SDV the more symmetrical the clusters present. Together these two 
statistics quantify the presence of clustering within tree topologies. The full genome and sub-
genomic phylogenies were uploaded as tree strings in Newick format into CTree, clusters were 
manually populated and then the tree metrics SDR and SDV were calculated.  
2.9. Cluster enumeration 
2.9.1. Identification of phylogenetic clusters using PhyloPart 
 
The HIV-1 sequences in clusters in the 7 sub-genomic phylogenies and in the full genome 
phylogeny were enumerated with PhyloPart ver. 2.1158. We defined the HIV cluster as a viral 
lineage that gives rise to a monophyletic sub-tree of the overall phylogeny with strong statistical 
support. We employed bootstrap re-sampling with 100 replicates to construct a consensus 
phylogenetic tree. We use the bootstrapped maximum likelihood method to determine the 
statistical support of clusters. We evaluated for transmission clusters among sequences that 
clustered around common proximal nodes with ≥ 90% bootstrap support. Of clusters containing 
> 2 sequences that met this criterion, we identified final transmission clusters as those in which 
each sequence had at least one neighbor within a patristic distance of ≤ 4.5% substitutions per 
site as measured via the length between branch tips on the originally generated phylogenetic 
tree. Clusters were identified using a depth-first algorithm158, a method for traversing or 
searching tree or graph data structures starting from the root. This approach allowed us to avoid 
double counting of viral sequences and clusters in any cases in which clusters had internal 
structure with strong support. 
2.9.2. Identification of phylogenetic clusters using PhyloType StandAlone PST07 
 
The HIV-1 full genome phylogeny, all 7 sub-genomic phylogenies and 171 sliding window 
length phylogenies were examined with the use of the PhyloType stand-alone application. The 
PhyloType application is a published application231, that allows for the quick, easy and unbiased 
analysis of large phylogenies that would normally have to be done manually, which is an 
extremely time consuming method. PhyloType is a tool that inspects phylogenies and combines 
them with extrinsic traits (e.g. geographic location, risk group, presence of a given resistance 
mutation), seeking to extract strain groups of specific interest or requiring surveillance. The 
primary annotations in this data set were the strain subtypes; these were grouped into the 
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countries in which the studied sequences were collected. An illustration of a PhyloType file 
annotation is presented in Figure 16. These PhyloType annotated files along with the 
corresponding tree files (in Newick specific file formats) were used to assess sequence 
clustering patterns based on geographical classification in the PhyloType application with a 
total of 1000 shuffling iterations in order to calculate p-values for each of the identified clades 
in the tree topologies. The criteria chosen for the PhyloType analysis were Size ≥ 5, Persistence 
≥ 1, Size/Different ≥ 1 and Support ≥ 0.7. The ACCTRAN parsimony method was selected and 
1000 shuffles were performed to test phylotype significance. Only those phylotypes whose P-
value for Size is ≤ 1% were retained. These options, selection criteria and thresholds correspond 
to PhyloType’s default parameter settings. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: An illustration of a Phylotype file annotation. This particular file annotation contains the 
strain (sequence ID) of each isolate, the subtype and the country code. This is the query file annotation 
that was uploaded into PhyloType to search the tree topology. This particular file annotation was 
generated in TextWrangler v 4.0.1. 
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CHAPTER THREE: RESULTS 
 
 
The following chapter contains the results of the study, the results are organized in two parts: 
(1) Results on the outcomes of the accuracy of phylogenies inferred from each genomic region. 
This part (section 3.1) will address the first aim of the study, that is, to determine if the usage of 
full-genome sequence data as opposed to sub-genomic data for phylogenetic tree construction 
results in a more accurate phylogenetic tree, measurable by tree certainty; subtype diversity 
ratio; subtype diversity variance; and Shimodaira-Hasegawa-like support values. (2) Results on 
the outcomes of clustering in phylogenies inferred from different sub-genomic regions and 
various window lengths. This part (section 3.2) will address the second aim of the study, that is, 
to elucidate the optimal window size (sequence length) and genomic region to accurately 
identify transmission clusters. The results that are presented in this chapter will then be 
discussed and compared with one another, as well as with the findings from other studies in the 
established scientific literature, in the following chapter. 
3.1 Accuracy of inferred phylogenies 
3.1.1. Hierarchy of tree certainty 
 
The degree of conflict or incongruence in the inferred trees was quantified by measuring tree 
certainty255. Table 11 displays the characteristics and hierarchy of tree certainty levels of the 
sub-genomic regions in descending order and comparative tree certainty is graphically presented 
in Figure 17. The tree based on full genome sequences showed the highest tree certainty. With 
a shorter sequence length than pol, the env tree had the highest certainty amongst the three 
structural HIV-1 genes, while the gag-based tree had the lowest certainty. The amount of 
variation that we find in env (length = 2750 nt) would be equivalent to an approximately 5 Kb-
long gag-pol sequence. This could explain that why env outperforms pol (length = 3012 nt). The 
partial env tree showed relatively low certainty at levels comparable with the gag tree certainty. 
The partial pol tree certainty was the lowest amongst all sub-genomic regions. The region that 
had the closest tree certainty levels relative to the full genome was the product 4 region. 
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Table 11: Characteristics and hierarchy of tree certainty amongst genomic regions 
Hierarchy of 
target region 
Coding region 
 
Length 
(Bp) 
Nucleotide 
positions (ref 
HXB2) 
Tree 
Certainty 
Relative 
Tree 
Certainty 
1. Full genome Enitre HIV-1 genome Entire 
Length 
Entire length 921.7 32.02 
2. Product 4 Spanning vpu, env, nef, 
and TATA-box in the 
U3 region of 3’ –LTR 
3551 5967 - 9517 724.38 25.17 
3. Env External glycoproteins 
gp120 and gp41 
2750 6045 - 8795 638.39 22.18 
4. Product 2 3’ -end of gag  and 
almost the entire pol 
3573 1486 - 5058 614.16 21.34 
5. Pol Reverse transcriptase, 
protease and integrase 
3012 2085 - 5096 583.02 20.26 
6. Partial env Gp120 V1C5 region 1188 6570 - 7757 510.27 17.73 
7. Gag Codes for internal 
virion proteins 
1502 790 - 2292 506.37 17.59 
8. Partial pol Protease and the first 
335 amino acids of 
reverse transcriptase 
1302 2253 - 3554 386.94 13.44 
 
 
 
Figure 17: Graph comparing relative tree certainty amongst phylogenies inferred from different HIV-1 
gene regions. Internode certainty was quantified by considering the two most prevalent conflicting 
bipartitions and calculating the log magnitude of their difference. Tree certainty was quantified as the sum 
of the internode certainty over all internodes in a phylogeny255. TC = Tree Certainty, FG = Full genome, 
P-Env = Partial Env, P-Pol = Partial Pol, Pro-2 = Product 2, Pro-4 = Product 4. 
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3.1.2. Hierarchy of quality of clustering  
 
Table 12 displays the characteristics and hierarchy of subtype diversity ratio (SDR) and subtype 
diversity variance (SDV) scores of the genomic regions in descending order of SDR scores. 
SDR and SDV scores are also graphically presented in Figure 18 and Figure 19 respectively. 
The SDR is a quantitative measure of the extent of clustering found within a tree, trees with 
lower SDR values are characterized by well defined clusters. With regards to SDV, the lower 
the value the more symmetrical, or equidistant, the clusters in a tree are relative to each other. 
The tree based on the partial env sequences had the best (lowest) SDR score, and the env tree 
had the best SDV score. Again, the product 4 region phylogeny had a SDR score comparable to 
the full genome phylogeny. 
 
Table 12: Characteristics and hierarchy of SDR and SDV amongst genomic regions 
Hierarchy of 
target region 
Coding region Length 
(Bp) 
Nucleotide 
positions 
(ref HXB2) 
Subtype 
diversity 
ratio score 
Subtype 
diversity 
variance score 
1. Partial env Gp120 V1C5 region 1188 6570 - 7757 0.7626 0.0272 
2. Env External 
glycoproteins gp120 
and gp41 
2750 6045 - 8795 0.7821 0.0063 
3. Product 4 Spanning vpu, env, 
nef, and TATA-box 
in the U3 region of 3’ 
–LTR 
3551 5967 - 9517 0.8143 0.0087 
4. Full genome Enitre HIV-1 genome Enitre 
Length 
Entire length 0.8303 0.0727 
5. Gag Codes for internal 
virion proteins 
1502 790 - 2292 0.8508 0.0150 
6. Pol Reverse transcriptase, 
protease and 
integrase 
3012 2085 - 5096 0.9009 0.0110 
7. Product 2 3’ -end of gag  and 
almost the entire pol 
3573 1486 - 5058 0.9043 0.0167 
8. Partial pol Protease and the first 
335 amino acids of 
reverse transcriptase 
1302 2253 - 3554 0.9117 0.0888 
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3.1.2.1. Quantified by subtype diversity ratio 
 
 
Figure 18: Subtype diversity ratio (SDR) score for each HIV-1 targeted genomic region phylogeny. The 
calculation of SDR scores was implemented in cTree229. Axis-y shows the magnitude of the SDR scores, 
Axis-x shows targeted regions across the HIV-1 genome. FG = Full genome, P-Env = Partial Env, P-Pol 
= Partial Pol, Pro-2 = Product 2, Pro-4 = Product 4. 
 
3.1.2.2. Quantified by subtype diversity variance 
 
 
Figure 19: Subtype diversity variance (SDV) score for each HIV-1 targeted genomic region phylogeny. 
Subtype diversity variance (SDV) score for each HIV-1 targeted genomic region phylogeny. The 
calculation of SDV scores was implemented in cTree229. Axis-y shows the magnitude of the SDV scores, 
Axis-x shows targeted regions across the HIV-1 genome. FG = Full genome, P-Env = Partial Env, P-Pol 
= Partial Pol, Pro-2 = Product 2, Pro-4 = Product 4. 
68	  
3.1.3. Hierarchy of Shimodaira-Hasegawa (SH) – like support 
 
 
Table 13 displays the characteristics and hierarchy of SH-like support values of the sub-
genomic regions in descending order and comparative SH-like support is graphically presented 
in Figure 20. Superiority of SH-like support values is graded in descending order, that is, the 
lower the value, the better the SH-like support. The tree based on full genome sequences had the 
best SH-like support value. As with the tree certainty outcomes, with a shorter sequence length 
than pol, the env tree had the best SH-like value amongst the three structural HIV-1 genes, 
while the gag-based tree had the worst score. Mirroring the hierarchy of tree certainty results, 
the region that had the closest tree SH-like support levels relative to the full genome was the 
product 4 region. 
 
Table 13: Characteristics and hierarchy of SH support amongst genomic regions 
Hierarchy of 
target region 
Coding region Length (Bp) Nucleotide 
positions (ref 
HXB2) 
SH-like 
support value 
(mean) 
1. Full genome Enitre HIV-1 genome Enitre Length Entire length -4539102.4215 
2. Product 4 Spanning vpu, env, 
nef, and TATA-box in 
the U3 region of 3’ –
LTR 
3551 5967 - 9517 -2486652.0891 
3. Env External glycoproteins 
gp120 and gp41 
2750 6045 - 8795 -2050291.3771 
4. Product 2 3’ -end of gag  and 
almost the entire pol 
3573 1486 - 5058 -1228841.2981 
5. Partial env Gp120 V1C5 region 1188 6570 - 7757 -1144029.9217 
6. Pol Reverse transcriptase, 
protease and integrase 
3012 2085 - 5096 -1020499.4236 
7. Gag Codes for internal 
virion proteins 
1502 790 - 2292 -884837.7213 
8. Partial pol Protease and the first 
335 amino acids of 
reverse transcriptase 
1302 2253 - 3554 -416874.9752 
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Figure 20: Graph comparing SH-like support values amongst phylogenies inferred from different HIV-1 
genomic regions. The calculation of SH-like support scores was implemented in RAxML255. Axis-y 
shows the magnitude of the SH-like support scores, Axis-x shows targeted regions across the HIV-1 
genome. FG = Full genome, P-Env = Partial Env, P-Pol = Partial Pol, Pro-2 = Product 2, Pro-4 = Product 
4. 
3.2. Extent of HIV clustering across the HIV-1 genome 
3.2.1. Clusters enumerated by PhyloPart in each genomic region phylogeny 
 
We addressed whether the extent of HIV clustering is associated with any particular HIV-1 gene 
or gene sub-region, this analysis was implemented in PhyloPart. This method is based on a 
depth-first search (an algorithm for traversing a tree where one starts at the root and explores as 
far as possible along each branch before backtracking) and conjugates the evaluation of node 
reliability, tree topology and patristic distance analysis. The proportion of clustered sequences 
was compared between full-genome HIV-1 sequences and sub-genomic regions. Three 
structural HIV-1 genes, gag, pol, and env, and four regions commonly used in HIV cluster 
analysis (partial pol, partial env, product 2 and product 4), were targeted. All sets of sequences 
included the same 2881 HIV-1 sequences. Clusters were enumerated at the bootstrap threshold 
of 0.9 for cluster definition, with a within-cluster genetic distance of 4.5% substitutions per site, 
under maximum likelihood inference.  
 
As shown in Figure 21, the highest number of clusters enumerated was observed for the 
product 2 phylogeny (402); a region associated with pol. Among the three structural HIV-1 
genes, the more conserved sub-genomic regions had the higher number of clusters enumerated 
as well as more sequences in clusters (Figure 22). The highest number of clusters enumerated 
and the highest proportion of HIV-1 sequences in clusters was found in pol (401 and 1377 
respectively) followed by gag (399 and 1345 respectively) and then env (226 and 645 
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respectively).  The full genome phylogeny had the 5th highest number of clusters and sequences 
in clusters as enumerated by PhyloPart analysis, a method that factors in patristic distance in its 
analysis. 
 
 
 
Figure 21: Number of clusters in the targeted regions of the HIV-1 genome. The number of HIV-1 
sequences in clusters was estimated in PhyloPart230. Axis-y shows the number of HIV-1 sequences in 
clusters, Axis-x shows targeted regions across the HIV-1 genome. FG = Full genome, P-Env = Partial 
Env, P-Pol = Partial Pol, Pro-2 = Product 2, Pro-4 = Product 4. 
 
 
 
Figure 22: The extent of HIV clustering in each targeted HIV-1 genomic region. The proportion of HIV-
1 sequences in clusters was estimated in PhyloPart230. Axis-y shows the proportion of HIV-1 sequences in 
clusters, Axis-x shows targeted regions across the HIV-1 genome. FG = Full genome, P-Env = Partial 
Env, P-Pol = Partial Pol, Pro-2 = Product 2, Pro-4 = Product 4 
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3.2.2. Clusters enumerated by PhyloType in each genomic region phylogeny 	  
Results are provided in Figure 23 and Figure 24 which show the number of phylotypes 
enumerated in each genomic phylogeny and the percentage of strains associated with 
phylotypes per genomic phylogeny respectively. The tree based on full genome sequences had 
the highest number of phylotypes enumerated (69), as well as the highest percent of strains 
associated with phylotypes (71%). This means that 71% of the 2881 sequences were in clusters. 
Overall, the profile of phylotype cluster enumeration data resembled the hierarchy of tree 
certainty and SH-like support values with the tree based on product 4 region sequences having 
the second highest percent of strains associated with phylotypes (70,3%), slightly lower than 
that of the full genome phylogeny. Among the three structural HIV-1 genes, the highest 
proportion of HIV sequences in clusters was found in pol, followed by gag and then env. Pol 
also had the highest number of phylotypes enumerated, env had the second highest and gag had 
the lowest. Thus a brief contrast of env and gag is that clustering outcomes that result from the 
usage of the env phylogeny are that of a relatively greater number of phylotypes with a smaller 
number of strains per phylotype.  	  
 
 
 
Figure 23: Number of phylotypes in the targeted regions of the HIV-1 genome. The number of HIV-1 
sequences in clusters was estimated in PhyloType231. Axis-y shows the number of HIV-1 phylotypes, 
Axis-x shows targeted regions across the HIV-1 genome. FG = Full genome, P-Env = Partial Env, P-Pol 
= Partial Pol, Pro-2 = Product 2, Pro-4 = Product 4. 
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Figure 24: Percentage of strains associated with phylotypes in the targeted regions of the HIV-1 genome. 
The percentage of strains was estimated in PhyloType231. Axis-y shows the proportion of HIV-1 strains in 
phylotypes, Axis-x shows targeted regions across the HIV-1 genome. FG = Full genome, P-Env = Partial 
Env, P-Pol = Partial Pol, Pro-2 = Product 2, Pro-4 = Product 4. 
 
Figure 25 – Figure 32 show the phylotype maps that indicate the succession of founder and 
migratory events reconstructed from each genomic phylogeny. According to the full genome 
phylotype map (Figure 26), the virus spread from 7 South African phylotypes and 1 phylotype 
from Botswana. The Botswanan phylotype spread directly into India, and 1 large South African 
phylotype (429:ZA) spread into Brazil, Botswana and Cameroon. The phylotype maps 
reconstructed from the sub-genomic regions show significantly different migratory events and 
inferior phylotype identification. For example, the env and gag phylotype maps show that only 
3 and 2 founder South African phylotypes were enumerated respectively. The subsequent 
sequence of migratory events is also varied when contrasting the different phylotype maps, as 
well as the number and identity of phylotypes of indirect origin (coloured in red). The env and 
product 4 phylotype maps enumerated the least number of phylotypes of indirect origin and the 
partial pol phylotype map had the most. 
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Figure 25: A subset of the env phylotype map (ACCTRAN) of global HIV-1. The map summarizes the 
information contained in the env phylogenetic tree; circle surface is proportional to the size value 
(number of members) of the phylotype. ZA = South Africa, BW = Botswana, CM = Cameroon, TH = 
Thailand, IR = Iran, RU = Russia, CN = China, UZ = Uzbekistan, AF = Afghanistan, CY = Cyprus, IN = 
India, JP = Japan, BR = Brazil, US = United States of America. Some of the phylotypes (coloured in red) 
have indirect origin; for example, 1815:BR and 2646:UZ. 
 
2:ZA
20:ZA
3:ZA
1717:BR
1557:BW
949:BW
1777:CM
965:IN
2267:CD
5682:CN
2170:CU
5695:ES
3056:MY
3704:MY
2721:RU
2915:TH
2930:TH
5667:TH
3850:ZA
1815:BR
2957:TH
3073:TH
2609:UA
2309:UG
3733:UG
3880:US
979:CN
1906:ES
1858:LU
2970:CN
3151:CN
3238:CN
3430:CN
3679:CN
3584:VN
3348:CN
2618:RU
2646:UZ
2334:AF
2319:IR
2379:KE
3823:GB
4204:BR
4382:BR
4772:FR
4509:JP
4917:KR
5226:CY
4575:TH
1060:IN
3360:VN
2397:CY
2472:IN
5453:BR
5393:JP
5320:US
5540:US
4605:CN
3056 TH
1815 BE
2609 CY
2646 KZ
74	  
 
 
 
 
Figure 26: A subset of the full genome phylotypes map (ACCTRAN) of global HIV-1. The map 
summarizes the information contained in the full genome phylogenetic tree; circle surface is proportional 
to the size value (number of members) of the phylotype. ZA = South Africa, BW = Botswana, CM = 
Cameroon, TH = Thailand, IR = Iran, RU = Russia, CN = China, UZ = Uzbekistan, AF = Afghanistan, 
UG = Uganda, IN = India, JP = Japan, BR = Brazil, US = United States of America, ES = Spain, NG = 
Niger, CU = Cuba, GB = United Kingdom, PE = Peru, KR = South Korea, LU = Luxembourg, FR = 
France. Some of the phylotypes (coloured in red) have indirect origin; for example, 4624:BR and 
2438:US.  
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Figure 27: A subset of the gag phylotype map (ACCTRAN) of global HIV-1. The map summarizes the 
information contained in the gag phylogenetic tree; circle surface is proportional to the size value 
(number of members) of the phylotype. ZA = South Africa, BW = Botswana, CM = Cameroon, IR = Iran, 
RU = Russia, UZ = Uzbekistan, AF = Afghanistan, CY = Cyprus, IN = India, JP = Japan, BR = Brazil, 
NG = Niger, TZ = Tanzania, UG = Uganda, LU = Luxembourg, UA = Ukraine, KR = South Korea. Some 
of the phylotypes (coloured in red) have indirect origin; for example, 158:IN and 800:CM.  
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Figure 28: A subset of the product 2 phylotype map (ACCTRAN) of global HIV-1. The map summarizes 
the information contained in the product 2 phylogenetic tree; circle surface is proportional to the size 
value (number of members) of the phylotype. ZA = South Africa, BW = Botswana, CM = Cameroon, TH 
= Thailand, CN = China, IN = India, BR = Brazil, US = United States of America, VN = Vietnam, SE = 
Sweden, UG = Uganda. Some of the phylotypes (coloured in red) have indirect origin; for example, 
21:ZA and 1582:US.  
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Figure 29: A subset of the product 4 phylotype map (ACCTRAN) of global HIV-1. The map summarizes 
the information contained in the product 4 phylogenetic tree; circle surface is proportional to the size 
value (number of members) of the phylotype. ZA = South Africa, BW = Botswana, CM = Cameroon, IR 
= Iran, RU = Russia, CN = China, IN = India, BR = Brazil, US = United States of America, NG = Niger, 
KE = Kenya, CD = Congo, The Democratic Republic of, MY = Malaysia, ES = Spain, UA = Ukraine, 
RW = Rwanda, GB = United Kingdom, CY = Cyprus. Some of the phylotypes (coloured in red) have 
indirect origin; for example, 184:ZA and 2093:BR. 
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Figure 30: A subset of the partial pol phylotype map (ACCTRAN) of global HIV-1. The map 
summarizes the information contained in the partial pol phylogenetic tree; circle surface is proportional to 
the size value (number of members) of the phylotype. ZA = South Africa, BW = Botswana, CM = 
Cameroon, TH = Thailand, SE = Sweden, RU = Russia, CN = China, VN = Vietnam, JP = Japan, BR = 
Brazil, US = United States of America, UG = Uganda. Some of the phylotypes (coloured in red) have 
indirect origin; for example, 287:BR and 4077:ZA. 
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Figure 31: A subset of the partial env phylotype map (ACCTRAN) of global HIV-1. The map 
summarizes the information contained in the partial env phylogenetic tree; circle surface is proportional to 
the size value (number of members) of the phylotype. ZA = South Africa, CM = Cameroon, TH = 
Thailand, IR = Iran, RU = Russia, CN = China, UZ = Uzbekistan, CY = Cyprus, BR = Brazil, US = 
United States of America, UG = Uganda, MY = Malaysia, GB = United Kingdom, VN = Vietnam, NG = 
Niger, UA = Ukraine. Some of the phylotypes (coloured in red) have indirect origin; for example, 
3635:ZA and 2499:UA. 
1293:US
1652:US
2:US
4:US
1620:JP
1655:BR
5498:CM
5605:CN
5509:UG
5480:ZA
1678:CM
3635:ZA
565:BR
1204:BR
880:CY
908:CY
409:ES
273:FR
508:JP
798:KR
1034:TH
2140:CD
1748:CU
1684:NG
2105:RU
1874:BR
2787:TH
2499:UA
2194:UG
5410:BR
5244:SE
4805:IN
1059:CN
1965:ES
2000:LU
2845:CN
3038:CN
3094:CN
3108:CN
3471:CN
3591:CN
3290:MY
3459:MY
2937:VN
2566:RU
2528:KZ
2230:AF
2283:KE
2375:KE
4813:CN
4917:CN
2975:CN
2540:UZ
2249:IR
2333:CY
2406:GB
2386:IN
5498 ES
5605 ES
5509 ES {CM ZA}
5480 ES
1678 ES
3635 ES
1874 BE
2499 RU
4805 BW
80	  
 
 
 
Figure 32: A subset of the pol phylotype map (ACCTRAN) of global HIV-1. The map summarizes the 
information contained in the pol phylogenetic tree; circle surface is proportional to the size value (number 
of members) of the phylotype. ZA = South Africa, BW = Botswana, CM = Cameroon, RU = Russia, CN 
= China, AF = Afghanistan, IN = India, BR = Brazil, US = United States of America, SE = Sweden, UG 
= Uganda, KE = Kenya, NG = Niger, ES = Spain, GH = Ghana, UA = Ukraine, CD = Congo, The 
Democratic Republic of. Some of the phylotypes (coloured in red) have indirect origin; for example, 
4120:BR and 340:SE.  	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3.2.3. Clusters enumerated by PhyloType in each sliding window length phylogeny 
 
To assess the extent of HIV clustering across the HIV-1 genome, sliding window analysis was 
performed with window sizes of 1000-bp; 2000-bp and 3000-bp, and sliding steps of 100 bp; 
200 bp; and 300 bp respectively. This analysis allowed us to investigate how patterns of HIV 
clustering change across the HIV-1 genome.  
 
A 
 
B 
 
 
Figure 33: Sliding window analysis across the HIV-1 genome depicting number of phylotypes. (A) HIV-
1 genome structure. The map is depicted as a reference to the gene structures associated with the various 
nucleotide positions across the HIV-1 genome. (B) The extent of HIV-1 clustering for each sliding 
window length.  
1000bp window 2000bp window 3000 bp window
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The profile of HIV clustering across the HIV-1 genome was ‘‘wave shaped’’ (Figure 33 and 
Figure 34) suggesting a differential contribution of regions across the HIV genome to 
clustering. The highest extent of HIV clustering was associated with the region encoding env. 
HIV-1 gag and the region from 4100nt to 4200nt (p15 RNase) showed the lowest extent of HIV 
clustering. The size of the sliding window has a moderate effect on the extent of HIV clustering. 
Longer viral sequences with window size 3000-bp were associated with slightly higher extents 
of HIV clustering than sequences with window sizes of 2000-bp and 1000-bp across the entire 
HIV genome (Figure 33). The ups and downs in the profiles of HIV clustering were similar 
between longer and shorter HIV windows. A deeper look into sliding windows across the viral 
genome reveals substantial heterogeneity in HIV clustering based on the sub-genomic region 
and sampling. Analysis of potential reasons for such a differential clustering across the viral 
genome, such as searching for specific signatures associated with clustering, warrants dedicated 
future studies and should be taken in the context of sampling. 
 
 
 
 
Figure 34: Sliding window analysis across the HIV-1 genome depicting extent of clustering. The 
percentage of strains associated with phylotypes for each sliding window length is shown in the y-axis 
and HIV-1 nucleotide positions are shown in the x-axis.  
 
1000bp window 2000bp window 3000 bp window
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CHAPTER FOUR: DISCUSSION 
 
The dynamics of HIV-1 transmission networks can be investigated through comprehensive HIV 
cluster analysis. HIV-1 transmission cluster analysis can provide insights into the dynamics of 
HIV-1 spread, and the results of HIV-1 cluster analysis can help inform public health 
prevention interventions, such as an optimal balance of Treatment-as-Prevention and Pre-
Exposure Prophylaxis strategies. The higher the extent of HIV clustering, the more informative 
HIV cluster analysis could be. In phylogenetics, there are a wide range of factors that may 
influence the results or outcomes of any investigation, and the inference of HIV-1 transmission 
clustering analysis is no exception. Since the start of HIV epidemic reconstruction in the 1990’s 
several concerns have been raised that may influence the validity of the results of such 
endeavours. These include: the effect of viral genetic diversity between strains or subtypes, the 
effect of viral recombination, the number of the taxa and fragment size of the data set, the 
specific model parameters that was used, and the effect of mutation rates.  
 
In this study we investigated whether the extent of HIV clustering is associated with the length 
of targeted HIV sequences, or with a particular sub-genomic region across the HIV-1 genome. 
The extent of HIV clustering was compared between the full genome and sub-genomic regions, 
and also among different sliding window lengths. The accuracy of each inferred phylogeny 
(reconstructed from full genome, sub-genomic and various sliding-window length sequences) 
was also probed through the computation of various clade confidence metrics. 
 
Tree accuracy and clustering outcomes 
 
Although previous phylogenetic studies have shown that large input taxa is positively associated 
with inferred tree accuracy258, we saw great differences between the tree accuracy outcomes of 
the full genome and sub-genomic phylogenies in spite of the considerable number of input 
sequences. In phylogenetic studies, the total size of the number of taxa included in transmission 
cluster analysis has been a concern as too many isolates would unnecessarily slow down 
analysis, while too few isolates would leave out too much of the genetic information that is 
needed to infer epidemic histories259. In an attempt to exclude data size as a confounding factor 
in inferred tree accuracy and clustering outcomes, we utilized a considerable size of input taxa.  
 
In our analysis, the phylogeny based on the full genome sequences showed the best tree 
accuracy; it ranked highest with regards to both tree certainty and SH-like support. Product 4, a 
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region spanning vpu, env, nef, and TATA-box in the U3 region of 3’ –LTR, had the best tree 
accuracy among the sub-genomic regions. Among the HIV-1 structural genes, env had the best 
tree certainty, SH-like support, SDR score and the best SDV score overall. The full genome 
HIV-1 sequences were associated with the highest extent of HIV clustering in the phylotype 
analysis. Among HIV-1 structural genes, pol showed the highest extent of clustering, followed 
by env. Combined with the extent of HIV-1 clustering, the tree accuracy estimates provide 
additional evidence that full genome HIV-1 sequences are the most informative choice for HIV 
cluster analysis. Env appears to be the best choice among the structural genes, as it fared best in 
the tree accuracy metrics and product 4 (a region that is associated with env), exhibited the 
second highest slightly tree accuracy and clustering outcomes. These results mirror those by 
Yebra et al217 who found that there was increased reliability of phylogeny reconstruction in 
simulated data when using env trees. The env portion of the HIV-1 genome is highly variable 
and is under more selective pressure when compared to the gag or the pol regions of the HIV-1. 
The fact that env trees can outperform the pol trees, suggests that, in principle, the higher 
evolutionary rate in env can improve reconstruction.  
 
The influence of sequence length on the outcomes of HIV-1 phylogenetic cluster analysis 
 
The total size of the nucleic fragments, as with any phylogenetic investigation, has been 
elucidated to play an important role in HIV-1 phylogenetic cluster analysis; however, this role 
hasn’t been adequately quantified. The size of the nucleic acid fragments not only determines 
the speed of the analysis, but larger fragments carry more genetic information than smaller 
fragments. It is generally regarded that a fragment length of 500 bp or more for HIV-1 carries 
enough genetic information for reasonable phylogenetic inference260.  
 
To explore the optimal sequence length for phylogenetic cluster analysis, sliding window 
analysis was performed with window sizes of 1000-bp; 2000-bp and 3000-bp, and sliding steps 
of 100 bp; 200 bp; and 300 bp respectively. The sequence size, or length, used in HIV cluster 
analysis appeared to have a moderate effect on the extent of HIV clustering. This was evident 
from the comparison of HIV clustering between three sliding windows, 1 000 bp, 2000 bp and 
3000 bp long, which were run across the entire HIV-1 genome with 100 bp, 200 bp and 300bp 
steps, respectively. The sliding window analysis also allowed us to identify regions across the 
HIV-1 genome with higher propensities for HIV clustering. Despite fluctuations across the 
HIV-1 genome, the extent of HIV clustering was moderately higher for larger sliding windows 
spanning similar regions in the HIV-1 genome.  
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With a sample size of 401, research conducted by Novitsky et al.58 elucidated dramatically 
higher HIV clustering for larger sliding windows; the influence of sequence length on viral 
clustering in this study may have been mitigated by the large number of taxa. Another factor 
that may have contributed to dissimilar results is the exclusive utilization of HIV-1C sequences 
in the previous study, whereas the dataset in this study was heterogeneous in HIV-1 subtypes. 
Correlation between sequence length and tree accuracy has also been probed before in a 
simulation study217. The results showed that the proportion of correct trees increased in almost 
direct proportion to the length of the sequences used. Thus a consolidation of previous and 
current findings is that viral sequence length has a positive association with both tree accuracy 
and extent of clustering, but the magnitude of the influence is negatively affected by the taxa 
size. 
 
Limitations and conclusion 
 
The 2881 sequences used in this study included recombinants and varied in subtype 
classification.  This may be a limitation as the specifics and nature of subtype recombination 
could either complicate or assist in the analysis of HIV clustering. For example, the analysis 
could be complicated due to incorrect estimation of evolutionary rates and a skewed molecular 
clock261, 262. HIV-1 subtypes have a large effect on the analysis of HIV-1 transmission clusters. 
Since the zoonosis of HIV from non-human primates to humans a large degree of genetic 
variation has accumulated amongst HIV-1 isolates263. These genetic variations have led to the 
rise of distinct HIV-1 strains or subtypes104. The reconstruction of transmission histories from 
sequence data relies heavily on the assumption of a molecular clock and the coalescent theory. 
The coalescent theory is broadly based on the tracing of isolates back in time until all isolates, 
and their genetic information, has coalesced to a single point back in the distant past264, 265. The 
inclusion of isolates from multiple subtypes of HIV-1 will therefore inherently have an effect on 
transmission cluster analysis266, and this effect may have been a limitation to our analysis.  
 
In summary, the results of this study provide evidence that the extent of HIV clustering is 
associated with the length of viral sequences used in cluster analysis. The use of longer genetic 
regions (such as concatenated gag, pol and env or gag-pol) will allow for a more reliable 
reconstruction of transmission events and better cluster enumeration. The traditional short pol 
sequences generated for resistance testing that are used in most molecular epidemiology studies 
are substantially less reliable. Full genome sequences could be considered the top choice for the 
86	  
most informative HIV cluster analysis. An alternative approach to HIV cluster analysis could be 
based on selected sub-genomic regions with an elevated extent of HIV clustering and high tree 
accuracy such as env. An effort to generate highly sampled datasets is also needed to increase 
our ability to reconstruct real HIV epidemics. 
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